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Abstract 
Experimental evolution of TetX2: correlating changes in fitness to 
their structural and functional origins 
by 
Katarzyna Walkiewicz 
The study of protein evolution and adaptation resides at the junction between the 
disciplines of biological chemistry and evolutionary biology. We chose the B. 
thetaiotaomicron tetracycline resistant enzyme TetX2, as our model system to study the 
biophysical basis for adaptation to antibiotics; a phenomenon that continuously poses 
global health challenges. In the work presented here, experimental evolution and 
biophysical characterization were used to identify and link the physicochemical 
properties of TetX2 and its adaptive mutants to increased resistance to minocycline. 
Bacteroides thetaiotaomicron TetX2 was previously identified as a novel 
oxidoreductase with broad activity against tetracyclines. Experimental evolution of E. 
coli expressing a chromosomal copy of tet(X2) was used to identify an adaptive mutation 
(TetX2r280A) that confers higher resistance to minocycline and tigecycline. In addition to 
TetX2T280A, a family of variants of TetX2 with single amino acid changes in TetX2 
sequence that conferred equal or higher resistance towards MCN was identified by error-
prone mutagenesis. Changes in fitness of E. coli carrying a single chromosomal copy of 
either wild-type or one of the mutant alleles were assessed by growth rate assays over a 
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range of minocycline concentrations. Despite similar in vivo performances of TetX2x280A 
and two other variants (TetX2N37u and TetX2N37iT), TetX2T280A was the only successful 
mutant in the adaption experiment suggesting that mutational supply may play an 
important role in evolutionary dynamics of populations undergoing adaptation. The most 
surprising result is that the differences in growth rates among TetX2 variants arise from 
small changes in in vitro catalytic activity and in vivo protein expression. 
The steady-state kinetic studies with minocycline and NADPH suggest a binary 
mechanism for antibiotic inactivation by TetX2 which is supported by the structural 
characteristics of the enzyme. The atomic structures of the best adaptive mutant 
TetX2-rc80A in complex with minocycline and tigecycline reveal the details of substrate 
recognition and show that the site of the mutation is ~18 A away from the active site 
suggesting an indirect mechanism for improved catalysis. 
Taken together, our data show that very small changes in the in vitro biochemical 
properties and expression levels can have surprisingly large fitness effects and are 
important during adaption. In addition, a promising preliminary mathematical model 
suggests that based on kinetic activity and in vivo expression levels the success of 
bacteria undergoing adaptation to antibiotics can be predicted. 
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Chapter 1 Introduction 
1.1. Mutations fuel adaptation 
Charles Darwin was the first to recognize that natural selection constitutes the 
basic mechanism for evolution. In his publication "On the Origin of Species" Darwin 
proposed that new functions arise by the accumulation of adaptive changes resulting in 
greater fitness over long periods of time (Darwin, 1859). Although controversial at the 
time, his work became the foundation for evolutionary biology. Spontaneous mutations 
are one of the most important sources of variation, but the rates at which they occur are 
very slow (~ 8.9x10"" per nucleotide per generation for E. coli) (Wielgoss et al., 2011). 
They arise as a result of aberrations in DNA recombination, replication and/or repair 
machinery and are constrained by the chemical properties of DNA. For example, 
transitions (A—>G or T—>C) are more common than transversions (A—»C, A—»T, T—>G, 
G—>C) , even though there is a higher probability for the latter to occur (Li, 1997; 
Wielgoss et al., 2011). More recently, it has been suggested that selective pressure 
increases the rate of mutations and allows observing the differences in fitness resulting 
from genetic change in a population (Rosenberg and Hastings, 2003). 
1.2. Adaptive walk to greater fitness along mutational landscapes as a 
framework for visualizing adaptation 
Adaptation happens through accumulation of mutations that lead to higher fitness, 
as determined by the reproductive success in a selective environment (Elena and Lenski, 
2003). Mayanard Smith used an adaptive landscape as a metaphor to describe this process 
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(Smith, 1970). Smith suggested that mutational pathways exist because changes in fitness 
occur in a step-like process through functional intermediates that can be imagined as a 
"walk" across a landscape to increased fitness (Figure 1.1). The fate of mutations during 
adaption depends on their effects on the fitness of the organism. In the simple case of a 
two-peak fitness landscape, under selection, intermediates (beneficial mutations) must 
increase in frequency (rise to fixation) in order to have a major influence on a population 
(Poelwijk, 2007).The adaptive walk continues through subsequent mutations that arise in 
the background of the previous successful mutant (Figure 1.1). The degeneracy of 
genetic code plays an important role in defining mutational diversity because some amino 
acid substitutions cannot be achieved through a single nucleotide change (e. g. Val 
(GUU) cannot be mutated to Ser (AGU) in a single step). 
Since Smith's original work, others have further confirmed this theory by studies 
showing that adaptation occurs over long-periods of time through a punctate process 
(Figure 1.1) (Elena et al., 1996; Gerrish and Lenski, 1998). Consequently, the smaller the 
fitness benefit conferred by a mutation, the longer it will take for the mutation to fix in a 
population due to clonal interference (Gerrish and Lenski, 1998). Most beneficial 
mutations are rare (Orr, 2003) and their success is dependent on several factors such as 
mutational rate, population size and the distribution of the fitness effects of other 
beneficial mutations present in a population (Arjan et al., 1999; Lang et al., 2011). 
Figure 1.1 Fitness landscape. 
A progression along the fitness landscape through two independent pathways (red or 
green) for identical populations adapted independently. Both populations start at low 
fitness and climbed towards an ultimate fitness peak via a step like process indicated by 
the dashed arrows where each dash is a step that overall leads to increased fitness. 
Reprinted by permission from Macmillan Publishers Ltd: Nature Reviews Genetics 
(Elena and Lenski, 2003), copyright (2003). 
The challenge in relating readily measured physicochemical properties to fitness 
is difficult because of the complex metabolic context of organisms. In addition, the 
selection conditions that give rise to mutations are usually not known. In order to 
overcome these challenges, scientists have turned to experimental evolution that allows a 
careful examination of the evolutionary process in the laboratory. 
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1.3. Experimental evolution 
Stephen J. Gould asked if "replaying life's tape" would always lead to the same 
result or in other words is evolution repeatable and what role does adaptation, chance and 
history play in this process (Gould, 1989). Richard Lenski and colleagues addressed the 
repeatability of evolution in a series of studies using long-term evolution experiments 
where 12 populations of Escherichia coli have been continuously adapted on glucose as 
limiting source for over 50,000 generations (Barrick et al., 2009; Cooper and Lenski, 
2000; Elena et al., 1996; Lenski and Travisano, 1994; Travisano et al., 1995). The results 
of this experiment have shown that all 12 populations achieved similar fitness, which 
provided evidence for reproducibility of evolutionary events. As expected, history and 
chance played an important role on the evolution of traits that only weakly correlated 
with fitness, such as cell size (Travisano et al., 1995). In addition, Lenski and Travisano 
(1994) observed that the 12 E. coli populations, after 2,000 generations, underwent 
significant increases in fitness that were drastically decreased between generations 5,000 
to 10,000. Together with subsequent studies they showed that initial gains in fitness are 
large and tend to level off with the increasing number of generations (Barrick et al., 2009; 
Betancourt and Bollback, 2006; Cooper and Lenski, 2000; Lenski and Travisano, 1994; 
Novella et al., 1995). 
Lenski's long-term evolution experiment has shown that experimental evolution 
on tractable organisms can be a powerful tool in understanding the principles of 
adaptation through natural selection. Microbial (Barrick et al., 2009; Cooper and Lenski, 
2000; Travisano, 1997) and viral (Bull and Wichman, 1998; Novella et al., 1995) 
populations are the most common model systems for evolution studies. Among many 
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advantages of this approach is the fact that experiments can be carried out for many 
generations under good control of the experimental conditions used during selection 
(Elena and Lenski, 2003). In addition, the intermediates of adaptation can be retained 
throughout experimental evolution and their fitness compared to both end point and 
ancestral strain (Elena and Lenski, 2003). Finally, recent technological advances with 
next generation DNA sequencing make examination of the entire genome and proteome 
of these organisms possible. 
In recent years growing advances in DNA technology shifted the focus of studies 
on experimental adaptation towards whole genome approach and have given rise to 
functional genomics (Conrad et al., 2011; Hajibabaei et al., 2007). Lessons learnt from 
these findings provide invaluable insights into the understanding of evolutionary 
dynamics of microbial populations undergoing adaptation, through mapping the 
mutational pathways during adaption to antibiotics in E. coli (Toprak et al., 2012), 
identifying the importance of intracellular interactions within a population for the 
mechanisms for resistance (Lee et al., 2010), and dissecting the complexity in the link 
between genomic and adaptive evolution (Barrick et al., 2009). In addition, the whole 
genome sequencing with DNA barcoding allowed investigators to measure the 
frequencies of specific alleles during adaptation of E. coli (Barrick et al., 2009; Lee and 
Palsson, 2010; Lee et al., 2010). These results were summarized by Conrad et al. and 
showed that single nucleotide substitutions are the most common mutations and typically 
constitute about two-thirds of all mutations (Conrad et al., 2011). Deletions, insertions 
and larger sequence movements are less frequent and make up 29%, 7% and 3% of all 
mutations observed, respectively (Conrad et al., 2011). 
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As described previously, the effect of beneficial mutations on fitness of organisms 
can be assessed through allelic replacement, where a mutation is introduced into an 
ancestral strain for growth rate determination or a direct competition assay for fitness. 
However, when multiple mutations are present this approach can be very time consuming 
and often not feasible. Focusing adaptation on a single gene greatly simplifies the 
identification of adaptive changes and enables a quantitative approach to study evolution. 
This approach is termed weak link (Counago et al., 2006; Counago and Shamoo, 2005). 
1.4. Functional synthesis as a powerful tool in understanding the link between 
genotype -phenotype- fitness 
Dean and Thornton coined the term "functional synthesis" to describe the 
convergence of molecular evolution, biochemistry and structural biology to deconvolute 
the complex relationship between biochemical function and evolutionary outcomes (Dean 
and Thornton, 2007). Molecular biology makes it possible to reconstitute changes in 
genes and to study their effects on the organism under controlled conditions while in vitro 
assays allow quantitative evaluation of a protein. Crystallographic studies on isolated 
proteins provide an additional means to evaluate how genetic changes make alterations in 
protein structure and function. Together, these methods serve as powerful tools for 
dissecting the role of individual mutations on the in vivo fitness and therefore provide a 
method to correlate population dynamics and changes in protein function. Most 
importantly, they serve as means to directly link genotypic changes to phenotypes 
possibly providing insights into the mechanisms of adaptation. The ultimate goal of 
functional synthesis would be to successfully predict evolutionary outcomes by 
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correlating the evolutionary events on a population level to the molecular phenotypes at 
the protein level. 
1.5. The link between greater fitness and the physiochemical properties of 
proteins 
Conceptually, understanding the relationship between molecular properties of 
adaptive mutants and their consequences on cellular function is relatively simple. First, 
mutations responsible for a particular level of fitness have to be identified along with 
their functional intermediates. Then, the biophysical properties of proteins and their 
effects on fitness have to be measured to provide a link between genotype, phenotype and 
fitness. Finally, a model relating fitness to function that captures mechanism of selection 
has to be developed. In practice, correlating the changes in genotype to phenotype and its 
effects on fitness has proven very challenging. However reducing the complexity of the 
system to a single gene greatly simplifies interpretation of results allows for quantitative 
analysis and most importantly enables determining the structural and biochemical basis 
of adaptation. This approach can be particularly important in turning evolutionary 
biology into a predictive science for the study of antibiotic resistance. 
What are the biophysical parameters that correlate with fitness? Natural selection 
favors mutations that improve cellular function and therefore it was postulated that 
changes in in vivo activities of enzymes essential for survival to specific selection 
environment closely correlate with organismal fitness (Kacser and Burns, 1981). This 
hypothesis was tested by Dean and colleagues who showed that growth rates of E. coli 
were indeed directly correlated with activity of single gene expressing [i-galactosidase 
(Dean et al., 1986). 
In enzyme evolution, genetic changes can potentially alter any of the parameters' 
that define their catalytic performance which include: Km, the Michaelis constant; kcu, the 
catalytic rate constant; enzyme concentration; and &cal/KM, enzyme efficiency (Watt and 
Dean, 2000). Km and &ca, can be directly altered by amino acid substitutions or by 
changes in stability, which affects the effective enzyme concentrations and therefore 
alters Vmax or kcat[E]totai. Enzyme concentration can also be altered by changes in 
regulatory genes that affect protein expression patterns and consequently alter the total 
enzyme concentrations. It is important to note, that although mutation affecting either £ta, 
or total enzyme concentration can have similar effects on the overall catalytic 
performance, there is a difference in fitness costs associated with these changes. Changes 
in enzyme concentration impose a significant burden because of costs associated with 
protein synthesis, whereas changes in &cal are usually traded off for stability (Romero and 
Arnold, 2009). 
1.5.1. Trade-off between protein function (activity) and stability dictates the 
evolutionary dynamics. 
The distribution of fitness effects of protein mutations changes exponentially. 
With the increasing number of mutations to a single protein, the chance for decrease or 
loss of function also increases (Figure 1.3) (Soskine and Tawfik, 2010). This is because 
proteins are only marginally stable and most mutations have destabilizing effects that can 
result in increased aggregation and degradation of proteins (DePristo et al., 2005). As 
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mentioned before, most mutations that affect protein function can have deleterious effects 
on protein stability and consequently change the in vivo expression protein levels. 
Therefore, the ability to maintain functional and structural integrity of an enzyme is 
critical during adaption. Proteins with higher stability can tolerate more initial mutations 
and therefore increase the number of possible subsequent mutations. For example, the 
number of functional mutations was significantly higher for a more stable variant of 
TEM-1 p-lactamase (M182T) when compared to of the wild-type enzyme (Bloom et al., 
2005). 
1.0 
0.6 -
e 
Q_ 
0.0 
s o to IS 20 
Average number of mutations per TEM1 gene (n) 
Figure 1.3. Protein fitness declines as the number of spontaneous mutations begins 
to accumulate. 
Blue corresponds to fitness of TEM-1 p-lactamase measured at wild-type ampicillin 
levels, 2500 |lg/ml, and red corresponds to fitness determined at lower concentration of 
12.5 H-g/ml. Both scenarios show a decline in fitness with the higher number of 
mutations, however at higher ampicillin concentration, the decline is very sharp 
compared to lower concentrations where more mutations maintain functional genes. 
Reprinted by permission from Nature Publishing Group: Nature Reviews Genetics 
(Soskine and Tawfik, 2010), copyright (2010). 
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Tokuriki et al. have argued that protein dynamism also plays a critical role in 
evolvability (Tokuriki and Tawfik, 2009b). The conformational variability due to side 
chain fluctuations or more radical domain movements can serve as basis of protein 
evolvability (Tokuriki and Tawfik, 2009b). This can be seen in enzymes which catalyze 
more than one reaction and often require flexibility for catalysis (Skopalik et al., 2008). 
For example, the most rigid variant of mammalian cytochromes P450, CYP2A6 exhibits 
narrow substrate specificity whereas another variant, CYP3A4, recognizes a broad range 
of substrates and is the most flexible (Skopalik et al., 2008). Directed evolution studies 
of TEM-1 ^-lactamase also show that mutations responsible for wider specificity were 
mostly located in flexible loops in the active site (Tokuriki et al., 2008). 
In general, proteins with marginal stabilities can tolerate fewer mutations because 
most will be on average, highly destabilizing. On the other hand, proteins with higher 
stability are likely to accept more mutations and consequently adapt further to new 
functions (Bloom et al., 2006). Francis Arnold referred to this phenomenon as the 
protein stability threshold (Romero and Arnold, 2009). The distance from the minimal 
stability threshold of a parent protein determines the number of tolerable changes. 
Proteins with higher a minimal stability margin can explore a wider mutation range and 
thus have a better opportunity to evolve new functions (Figure 1.4). Stabilizing 
mutations often occur in the background of adaptive mutations that improve function but 
decrease stability. 
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Figure 1.4. Stability threshold in protein evolution. 
The distance from the minimal stability threshold (dashed line) of a parent protein 
determines the number of tolerable changes. Proteins with marginal stabilities (top panel) 
can tolerate fewer mutations (green area) because most mutations are highly 
destabilizing. On the other hand, proteins with higher minimal stability margin (bottom 
panel) can explore wider mutation range and thus can tolerate more mutations (green 
area). Reprinted by permission from Nature Publishing Group: Nature Reviews 
Molecular Cell Biology (Romero and Arnold, 2009), copyright (2009). 
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Using in vitro directed evolution, Weinreich et al. have shown that the effect of 
single amino acids substitution in (3-lactamase on the resistance of an organism was 
highly dependent on the order and the genetic background in which the mutations arose 
(Weinreich et al., 2006). The benefit of each individual mutation on the resistance of the 
organism was greatly decreased in the absence of the other mutations, which is due to the 
fact that some mutations, e.g. G238S, increase the activity of the enzyme while others, 
e.g. E104K improved protein's stability, showing that only when both mutations were 
present simultaneously, the optimal organismal fitness was reached (Orencia et al., 2001). 
This work highlights the importance of epistasis during adaptation. Epistasis defines the 
dependence of the fitness effect of a particular mutation on the genetic background that it 
appears in a selective environment (Weinreich et al., 2005) Consequently, epistasis 
determines the interaction of accessible mutations and produces constrained pathways 
that are able to maintain both protein activity and stability (Salverda et al., 2011; 
Weinreich et al., 2005). 
1.5.2. Non-adaptive mutations play an important role in evolutionary dynamics 
During adaptation, not all selected mutations are adaptive. Mutations that do not 
directly improve protein function can be selected for in the presence of compensatory 
mechanisms. The mutational effects can be buffered intrinsically by compensatory 
mutations or through extrinsic mechanisms, e.g. gene duplication events, regulatory 
mechanisms and chaperones (Camps et al., 2007; Soskine and Tawfik, 2010). Gene 
duplication helps to buffer otherwise deleterious mutations by relaxing the selective 
pressure. A duplication event often leads to increased protein level but also provides new 
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material for selection which consequently opens up new adaptive pathways. In addition, 
duplication can produce genes under control of different regulatory elements, which may 
also lead to new functions. Upregulation of protein expression has also been recognized 
as a compensatory mechanism in the adaptation of TEM-1 to higher antibiotic 
concentrations where a single mutation to a promoter was responsible for 10-fold 
increases in protein levels (Goldsmith and Tawfik, 2009). Chaperones or heat shock 
proteins also play important roles in buffering the effects of mutations that lead to 
misfolding or aggregation. For example, the number of tolerable mutations was increased 
by two fold when chaperones GroEL/GroES were overexpressed in Escherichia coli 
(Tokuriki and Tawfik, 2009a). Finally, compensatory mutations are often found to 
accompany adaptive mutations that improve function but also decrease stability. These 
mutations play an important role in evolutionary dynamics because they allow access to 
otherwise inaccessibly to adaptive pathways (DePristo et al., 2005; Tokuriki and Tawfik, 
2009b). In resistance of (3-lactamese towards cefataxime, compensatory mutations were 
necessary to restore organismal fitness (Orencia et al., 2001). In this system, mutation 
G238S that improved enzymatic catalysis was accompanied by the stabilization mutation 
M182T that always appeared in its background (Orencia, 2001). 
1.5.3. Experimental tests linking biophysical properties of enzymes to 
organismal fitness 
To date, several studies on molecular evolution of enzymes have shown that 
based on their biophysical properties a quantitative link between enzyme function and 
fitness can be derived (for review see (Dean and Thornton, 2007). One of the most 
characterized model systems to study adaptation of antibiotic resistance is ^-lactamase, 
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which is known to confer resistance to penicillins. Multiple variants of TEM-1 p-
lactamase with increased resistance towards cefataxime (a third generation 
cephalosporin) have been identified in natural and in laboratory settings. Directed 
evolution of TEM-1 P-lactamase, was successful in recapitulating clinically relevant 
mutations responsible for increased resistance towards cefataxime (Orencia, 2001). 
Analysis of the crystal structure of TEM-52 (a triple mutant of the TEM-1 P-lactamase -
clinical isolate) revealed that mutation G238S, which increases the Minimal Inhibitory 
Concentration (MIC) towards cefataxime about eight fold was located in the active site of 
the protein and resulted in a widening of the catalytic site but simultaneously lowered 
stability of the enzyme. When G238S is combined with a second mutation, E104K, a 
significant increase in the MIC for cefataxime (267 fold) was observed (Orencia et al., 
2001). The role of a third mutation, Ml 82T was to compensate the destabilized effects of 
the other variants as M182T by itself does not increase the MIC (Orencia, 2001). 
Individual mutations alone did not have great fitness effects when compared to 
combinations of mutations, supporting important role of epistasis (discussed in section 
1.5.1). A recent directed evolution study of a metallo-P-lactamase identified mutants that 
altered catalysis of the enzyme by altering flexibility (Tomatis et al., 2008). Flexibility 
was directly linked to higher fitness (resistance) and showed that protein dynamics can be 
a target for natural selection to act upon particularly in enzymes. 
Counago et al. (2006) established a direct link between changes in fitness and an 
increase of enzymatic stability and activity (Counago et al., 2006). In this study, 
adaptation of a single maladapted essential gene encoding adenylate kinase (adk) was 
investigated. The biophysical analysis of mutants that arose during adaptation of the adk 
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gene to temperature revealed a shift in the activity maxima, stability and kinetic 
properties of all mutant enzymes. Further characterization of the mutant enzymes was 
linked to protein activity and folding dynamics (Counago et al., 2008; Pena et al., 2010). 
In addition, based on the in vitro properties of the mutant enzymes, a fitness function was 
built to capture the evolutionary trajectories in the population and to predict the success 
of adaptive mutants during adaptation of adenylate kinase to temperature (Counago et al., 
2006; Pena et al., 2010). This study has shown that molecular properties that result from 
adaptation can be used to build a model that predicts evolutionary population dynamics. 
Ultimately, this work became the inspiration and provided basis for research presented in 
this thesis. 
1.6. Focus of this thesis 
The combination of experimental evolution to identify adaptive changes in 
proteins undergoing selection, and their subsequent physicochemical characterization, 
provides a physical basis for linking changes in protein structure and function to 
organismal fitness. This is particularly relevant for the study of antibiotic resistance 
where the evolution of drug resistant bacteria is clinically important. Therefore, we set to 
discover the principles that govern the adaptation of naturally evolved Escherichia coli 
strains to tetracycline antibiotics and develop a quantitative model predicting the 
outcomes in evolution of antibiotic resistance to this class of drugs. 
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1.7. Antibiotic resistance: origins and mechanisms of drug resistance 
Natural selection of antibiotic resistant pathogens is a continuously growing 
global challenge (Andersson and Hughes, 2010). Introduction of new antibiotics into 
clinics is almost immediately succeeded by incredibly fast emergence and proliferation of 
antibiotic resistant bacteria (Alekshun and Levy, 2007). Today, resistance to all clinically 
available antibiotics has been observed worldwide (Cohen, 2000). Although it might be 
tempting to view the rise of resistant pathogens as solely linked to the extensive use of 
antibiotics in clinical and agricultural environments, recent data suggest that spread of 
antibiotic resistance genes is an ancient and naturally occurring phenomena (D'Costa et 
al., 2011). This finding poses new challenges in the development of novel therapeutics 
and strategies used for their implementation, leading to the fundamental question; what is 
the biophysical basis for resistance? Most clinically available antibiotics originate from 
naturally occurring compounds produced by microorganisms such as fungi or soil-
dwelling bacteria (Walsh, 2000). They are mainly targeted at cell wall biosynthesis, DNA 
replication and repair, or protein synthesis. 
The determinants of resistance are often located on different mobile genetic 
elements such as plasmids, transposons and bacteriophages that can be transferred 
between the same and different bacterial taxonomic groups (Levy and Marshall, 2004). In 
addition, drug resistance can be altered intrinsically through a step-wise mechanism 
which occurs by the sequential accumulation of chromosomal mutations that result in the 
upregulation of the gene expression responsible for resistance or the modification of a 
pre-existing protein for new specificity (Alekshun and Levy, 2007). Despite different 
molecular mechanisms, natural selection is the common driving force that leads microbial 
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populations to adapt to certain drugs by improving their fitness in the environment 
(Barlow and Hall, 2003; Elena and Lenski, 2003; Hall, 2004). 
1.8. Tetracycline resistance as a model for experimental evolution 
Tetracyclines (Figure 1.5) are broad-spectrum antibiotics that inhibit protein 
synthesis by non-covalently binding to the ribosome and blocking the binding of 
aminoacyl-tRNA to the ribosomal acceptor site (Speer et al., 1992). A high-affinity 
binding site for tetracycline is located on the 30S ribosomal subunit (Connell et al., 
2003). Two independent crystal structures of the tetracycline-bound 30S subunit showed 
either two (Brodersen et al., 2000) or six (Pioletti et al., 2001) binding sites and it remains 
unclear as to which sites are inhibitory (Figure 1.6). 
Since their discovery in the 1940's, tetracyclines have been commonly used in 
medicine against both Gram-positive and Gram-negative bacteria, atypical organisms and 
protozoan parasites, as well as in agriculture as animal growth promoters (Chopra and 
Roberts, 2001). Their broad use in medicine, agriculture and aquaculture has resulted in 
an increase of tetracycline resistance (Thaker et al., 2010). 
To date, 40 proteins that confer tetracycline resistance have been identified 
(Thaker et al., 2010). These proteins are classified into three groups based on their 
mechanism of resistance: efflux, ribosomal protection, and enzymatic (Figure 1.7). The 
efflux class of tetracycline resistance proteins is common in Gram negative bacteria 
(Shigella and Salmonella) (Chopra and Roberts, 2001). All efflux tetracycline resistance 
proteins export tetracycline from the cell, which reduces the intracellular drug 
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concentration (Chopra and Roberts, 2001). TetA is one of the most common members of 
this class and often complements the ribosomal protection proteins 
CHL OH 
H X H DOXYCYCLINE 
(CH3)2N 
H ^ H MINOCYCLINE 
CH, OH OH 
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CI CH3 OH 
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ONH, 
Figure 1.5. Chemical structures of tetracycline derivatives. 
Tetracyclines share a common conserved structure shown on the bottom of the figure that 
consists of four (tetra) hydrocarbon rings. Tetracycline derivatives differ amongst each 
other by chemical modification of positions shown in a box on the conserved structure. 
Modifications to the hydrophobic portion of the molecule are known to inhibit its 
ribosome binding. Reprinted by permission from American Society of Microbiology, 
Clinical Microbiology Review:(Speer et al., 1992), copyright (1992). 
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Figure 1.6. Tetracycline binding sites on the 30S ribosomal subunit. 
Tetracycline binding sites determined by Pioletti et al. with tetracycline bound at several 
sites. The increasing numbers Tet-1 to Tet-6 indicates the relative occupancy in the 
electron density map. B) Primary tetracycline binding site is shown in red and secondary 
site in orange as determined by Brodensen et al. Red binding sites on both structures 
overlap suggesting that this could be a high-affinity binding site. Reprinted by permission 
from American Society of Microbiology Antimicrobial Agents and Chemotherapy: 
(Connell et al., 2003), copyright (2003). 
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Figure 1.7. Different mechanisms of tetracycline resistance. 
Tetracyclines accumulate inside the cell at high enough concentrations to inhibit protein 
translation. Bacteria can upregulate efflux pumps (TetA) that translocate antibiotics out 
of the cell, lowering their internal concentrations. In a different scenario, ribosomal 
protection proteins are expressed (TetM -green) that bind to the ribosome and displace 
tetracycline (yellow). A less common mechanism for tetracycline resistance is through 
expression of soluble enzymes (TetX -blue) that bind and enzymatically deactivate 
tetracyclines. 
The ribosomal protection class of proteins (RPPs) achieve tetracycline resistance 
by releasing bound tetracycline from the ribosome (Connell et al., 2003). This is the most 
common mechanism among all tetracycline resistance strains. An example of a RPP that 
has been well characterized is TetM. This 73 kDa protein was initially isolated from 
Streptococcus and has been found in a wide range of pathogens including mycoplasmas, 
Neisseria gonorrhoeae, Clostridia difficile and Staphylococci (Burdett, 1991). It shows 
75% sequence identity to TetO, a RPP that has been studied extensively. In addition, both 
21 
TetM and TetO share a 25% sequence identity in the N-terminal region to E. coli EF-G, 
thus suggesting how they might bind to the ribosome. When TetM binds to the ribosome, 
the tetracycline dissociation constant increases from 5 to 30 fiM causing its displacement 
(Connell et al., 2003). The cryo-EM studies of TetO indicated that RPPs bind to the 
ribosome in a manner similar to EF-G (Spahn et al., 2001). 
Enzymatic modification was not associated with the inactivation of tetracyclines 
until the discovery of TetX isolated from Bacteroides transposons 7W4351/7W4400 (Speer 
et al., 1991). TetX is a 44 kDa flavin adenine dinucleotide (FAD) containing 
monooxygenase that requires NADPH and oxygen for its enzymatic activity (Wangrong 
Yang, 2004). Predictions based on primary sequence analysis reveal the presence of a 
flavin-binding domain at the N-terminus end followed by a Pfam monooxygenase fold at 
the C-terminus end (Wangrong Yang, 2004). Two orthologs of tetX have been identified 
from another transposons, CTnDOT, in Bacteroides (Whittle et al., 2001). TetXl shows 
66% identity to TetX, but it is lacking the FAD binding domain. TetX2 shows 99% 
identity to TetX (Figure 1.8). 
Signature monooxygenase fold 
Signature monooxygenase fold 
Signature monooxygenase fold 
TetX 
TetXl 
TetX2 
Figure 1.8. Architecture of TetX from Bacteroides fragilis 7>j4351/77*4400 and its 
orthologs TetXl and TetX2 from Bacteroides trasposon CTnDOT. 
Recently, the molecular mechanism by which TetX2 deactivates tetracycline has 
been elucidated (Wangrong Yang, 2004). TetX2 hydroxylates tetracycline at position 
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CI la in the presence of NADPH, O2 and MgC^. The product of this reaction is unstable 
at physiological pH and causes a change in color of the reaction mixture from yellow to 
reddish brown. In addition, TetX can inactivate Tygacil®, a tetracycline antibiotic that 
was recently approved by the FDA (Figure 1.9), thus suggesting a possible emergent 
threat in the clinical environment (Moore et al., 2005). 
TetX NADPH, 02. MgCI2 
Figure 1.9. Regiospecific hydroxylation of tigecycline catalyzed by TetX2 in the 
presence of NADPH, O2 and MgC^. 
The inactivation of tigecycline results in the formation of 1 la-hydroxytigecycline by 
hydroxylation at position 1 la (Moore et al., 2005). 
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1.9. Objectives of this research 
Experimental evolution studies on microbial population have been focused on 
establishing a link between genetic variation and fitness and successfully shown that 
adaptation, history and chance play an important role on evolutionary outcomes. On the 
other hand, the biophysical studies of adaptive mutations have only recently started to 
identify biophysical properties that correlate protein function with organismal fitness. 
The thesis work presented here aims to bridge experimental evolution with the 
biophysical analysis of a specific class of adaptive mutations to investigate the 
biochemical and structural basis for adaptation in a quantitative manner. The specific aim 
of this work is to test the hypothesis that physicochemical characterization of all potential 
adaptive mutants provides basis for predicting evolutionary dynamics of a microbial 
population undergoing adaptation to antibiotics. As our model system we chose 
Bacteroides thetaiotaomicron TetX2 that was previously identified as a novel 
oxidoreductase with broad activity against tetracyclines (Wangrong Yang, 2004). 
First, we adapted E. coli expressing a chromosomal copy of tetX2 to increasing 
minocycline concentrations where we identified a single adaptive mutant with increased 
resistance towards MCN. We then used in vitro error-prone mutagenesis to identify all 
possible adaptive mutants of TetX2 and tested their in vivo fitness using a growth rate 
assay at clinically relevant drug concentrations. The outcomes of these experiments are 
presented in Chapter 3. Second, we characterized the biophysical and structural 
properties of mutant enzymes using X-ray crystallography and kinetics to characterize the 
enzymes and link the physicochemical properties of adaptive mutants to increased 
organismal fitness under specific selection conditions (i.e. relevant MCN concentration 
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and temperature). These results are shown in Chapter 4 (kinetics) and Chapter 5 
(crystallography). Finally, in Chapter 6, I discuss the overall finding from this thesis 
work and our current and future efforts in building an in silico model to test whether 
using experimental data we can predict the in vivo growth rates of adaptive mutants and 
their evolutionary dynamics in a population undergoing selection. 
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Chapter 2 Materials and Methods 
2.1. Strains and constructs 
2.1.1. Construction of strains used for natural evolution experiments and growth 
studies 
Integration of tet(X2) into the chromosome of E. coli strain BW25113 [F-, 
A(araD-araB)567, AIacZ4787(::rrnB-3), lambda- ,rph-l, A(rhaD-rhaB)568, hsdR514, 
pKD46] was performed using a short homology recombineering approach (Datsenko and 
Wanner, 2000). This method was introduced by Datsenko and Wanner (2000) and relies 
on phage X Red recombinase expressed from a low copy plasmid pKD46. This plasmid is 
a temperate sensitive replicon, so it is easily cured by shifting the growth temperature 
from 30 to 37°C. Tet(X2) was recombined into the well regulated spc operon of E. coli 
between prlA (SecY) and rmpJ (L36) (Figure 2.1). Linear DNA containing a ribosome 
binding site (rbs) and tet(X2) sequence flanked by short homologous sequences to prlA 
and rpmJ was amplified by Polymerase Chain Reaction (PCR) using $UC\9-tet(X2) 
construct as a template. Vector pUC19-tet(X2) was constructed by subcloning tet(X2) 
into a pUC19 vector behind a constitutively active lacZ promoter (Invitrogen, Carlsbad, 
CA). Forward primer used for amplification of tet(X2) included 50 nts homologous to a 
sequence on prlA and 20 nt long sequences corresponding to the ribosome binding site 
(rbs) located upstream of tet(X2) in pUC19 vector. Reverse primer included a 50 nt 
homologous to a sequence on rpmJ and the last 24 nt of tet(X2). Primer sequences are 
shown below: The sequences corresponding to the chromosomal insertions sites are 
underlined. 
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5'GAAGAAGGCGAACCTGAAAGGCTACGGCCGATAATTGGTCGCCCGAGAAG 
TAGAGGACCTAGAAGGAGAC (forward) 
5'CGGCATAATTTCTTGACGGAAGCACGAACTTTCATTTTTACTCTCCGTAA 
CTT ATT AT AC ATTT A AC A ATTGCTG (reverse) 
Figure 2.1. Schematic representation of short homology recombineering strategy 
used for integration of tet(X2) into the spc operon of E. coli. 
Recombinants were screened on LB agar plates containing 10 |ig/ml of 
tetracycline. Conformation PCR was performed using genomic DNA isolated from 
colonies grown at 10 |ig/ml of tetracycline using UltraClean® Microbial DNA Isolation 
Kit (MO BIO Laboratories, Inc., Carlsbad, CA) with primers aligning to the chromosome 
outside of the integration site (5' ATGGCT AA AC A ACCGGGATT AGATTTTC A A AGT 
GC and 5' GCGATTACGGCATGCTTATGATCAGGAATG). In the case of successful 
recombination, the PCR product amplified with these primers was expected to consist of 
3kb whereas, if the gene of interest was not integrated, then the product was only 1,8kB. 
HR HR 
E coli chromosome 
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The 3 kb PCR products were sent for sequencing for final confirmation of successful 
integration (all sequencing was done by SeqWright Inc, Houston, TX). Furthermore, the 
temperature sensitive helper vector pKD46 was cured by growth at 37°C overnight. Cells 
grown at temperature not permissive for the replication of the vector pKD46 lost their 
ability to grow on ampicillin (pKD46 harbors bla). Glycerol stocks of BW25113 cells 
carrying chromosomal copy of gene of interest were prepared by mixing 50% sterile 
glycerol and overnight liquid cultures in 1:2 ratios and were stored at -80°C. All mutants 
examined in this study were integrated into the chromosome using the same primers and 
procedures as used for the wild-type tet(X) gene. 
2.1.2. Generation of constructs for expression of mutant enzymes 
The original vector harboring wild-type tet(X2) was a generous gift from Dr. G. 
D. Wright (McMaster University, Canada). All mutant enzymes examined in this study 
were introduced into tet(X2) by site-directed mutagenesis using QuikChange II Site-
Directed Mutagenesis Kit (Agilent Technologies, Incorporated, Santa Clara, California) 
with an expression vector, pET-28b(+) containing Bacteroides thetaiotaomicron tet(X2) 
(residues 11-388) as a template. Primers for the mutants are listed below: 
Primer pair for T280S: 
5' CTACAAAGAATTGATTCATTCGACGTTGTCATTTGTAGG 3' 
5' CCTACAAATGACAACGTCGAATGAATCAATTCTTTGTAG 3' 
Primer pair for F235Y: 
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5' CCA AT A AT A ATGGTGC ATTGC ATT ATGG A AT A AGTTTT A A A AC ACCTG 3' 
5' C AGGTGTTTT A A A ACTT ATTCC ATA ATGC AATGC ACC ATT ATT ATTGG 3' 
Primer pair for N3711: 
5' CACAAGAAGAATCAACTCAAATCGAAATTGAAATGTTTAAACC 3' 
5' GGTTTAAACATTTCAATTTCGATTTGAGTTGATTCTTCTTGTG 3' 
Primer pair for N371T: 
5' CACAAGAAGAATCAACTCAAACCGAAATTGAAATGTTTAAAC 3' 
5' GTTTAAACATTTCAATTTCGGTTTGAGTTGATTCTTCTTGTG 3' 
Primer pair for K64R: 
5' CCTTGACCTACACAGAGGTTCAGGTCAG 3' 
5' CTGACCTGAACCTCTGTGTAGGTCAAGG 3' 
Primer pair for S326I: 
5' GC AGGG AGT A A AT ATTGGGTTGGTGG ATGC 3' 
5' GC ATCC ACC A ACCC AAT ATTT ACTCCCTGC 3' 
Mutagenesis reactions were performed according to the protocols supplemented 
with the kit. The reaction products were transformed into chemically competent XL-1 
Blue cells (Agilent Technologies, Incorporated, Santa Clara, California) and were plated 
on LB-agar plates containing 50 (Ag/ml kanamycin. Plasmid DNA was isolated from 
single-colonies using Wizard® Plus SV Minipreps DNA purification system (Promega, 
Madison, WI) and the DNA encoding tet(X2) was sequenced. 
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2.2. Serial-passage experiment 
Adaptation of E. coli BW251 \3-tet(X2) to increasing minocycline (MCN) 
concentrations was performed by serial transfer experiment carried out in 250 mL 
Erlenmeyer flasks (Figure 3.1). MCN concentrations below the Minimal Inhibitory 
Concentration (MIC) values were used as starting dosage for the serial-passage evolution 
experiments. The experiments were performed in 50 mL of sterilized LB media 
supplemented with MCN concentrations ranging between 2 to 5 ng/mL over 3 days for E. 
coli BW25113 and from 10 to 320 ^ig/mL over 10 days for E. coli BW25113-tet(X2). 
Each day a 50 jil of overnight culture was transferred to fresh LB broth supplemented 
with higher antibiotic concentration and was incubated in an orbital shaker shaking at 250 
revolutions per minute (RPM) overnight at 37°C. The drug dosages were increased daily 
according to the following schedule 10, 16, 24, 36, 52, 80, 120, 180, 300, 320 Jig/ml of 
final MCN concentration from day 1 to day 10. Samples from each day of the maintained 
culture were 1) plated on LB-agar plates and genomic DNA originating from single 
colonies was purified and the tet(X2) gene sequenced 2) stored as glycerol stock at -80°C. 
The serial passage experiment was repeated twice under the same conditions. 
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2.3. Determination of Minimal Inhibitory Concentrations (MICs) 
Minimum inhibitory concentrations (MIC) were determined by agar-dilution 
method (Figure 3.2) according to the National Council of Clinical Laboratory Service 
(NCCLS) guidelines where, the MIC is defined as minimum concentration of antibiotics 
that prevents visible growth. Briefly, E. coli BW25113-tet(X2) and E. coli BW25I13-
tet(X2)T280A cells from glycerol stocks were plated on cation-adjusted Mueller-Hinton 
agar (MHA) plates. MHA plates containing serially diluted antibiotics (minocycline, 
tetracycline or tigecycline) were prepared at concentrations ranging between 2-128 
fig/ml. Sterile loops were used to prepare inocula from cells grown on non-selective 
MHA plates that were diluted in MH broth to OD = 0.08-0.1 and were set aside. A subset 
of these cells were further diluted by 10-fold right before spotting 10 jjJ on MHA plates. 
Cells diluted to OD= 0.08-0.1 were used in an E-test (Figure 3.3). For this test, 
commercially available E-strips (AB Biodisk, bioMerieux, Incorporated, Durham, NC) 
containing a gradation of antibiotics were used to determine the MIC values for 
minocycline also on cation-adjusted MHA. Cells were evenly distributed across MHA 
plate using a cotton swab and E-strip was plated in the center. As soon as the strip is laid 
on the plates, the antibiotics diffuse into the agar. After 24 hour incubation period at 
37°C, zone of inhibition which formed an ellipsoid was examined. The values at which 
the ellipsoid touched the strip were considered the MICs. 
The drug dosages for evolution experiments were designed based on the MIC 
tests performed in liquid media. Single colonies were used to inoculate 10 mL LB media 
grown for eight hours. 10 fil of each of these cultures were used to inoculate 10 ml LB 
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liquid media containing MCN concentrations ranging from 0 to 100 ng/mL for the 
BW25113-tet(X2). The cells were then incubated at 37°C overnight and MIC values 
were determined to be the lowest concentrations at which the cells failed to grow within 
24 hours. MICs for MCN of evolved strain (day 9) were also determined by MIC test in 
liquid media. 
2.4. Determination of Growth Rates at Various Minocycline Concentrations 
Growth rates of E. coli expressing chromosomal copies of variant 
enzymes were measured and compared at various MCN concentrations ranging from 0-
50 fig/ml. Cells BW25113 preserved in glycerol stocks were re-streaked on fresh LB-agar 
plates containing 10 Hg/ml of tetracycline. Single colonies were picked and used to 
inoculate 1 mL of sterile LB in a deep well 96-well block and were incubated in an 
orbital shaker at 37°C for 24 hours. The stationary cultures were diluted 100 times in LB 
containing appropriate MCN concentrations (990 fiL of LB was mixed with 10 p.L of 
overnight culture) and 150 pL of the mixture was transferred to a 96-well flat bottom 
plate (BD Falcon, BD, NJ). Growth of bacteria was monitored by measuring the 
absorbance at 600 nm recorded every 5 minutes over 24 hours in a Synergy 2 micoplate 
reader (BioteK®, Winooski, VA, USA).The fastest growth was defined as a slope of a 
tangent parallel to linear log phase growth. The experiments were done in triplicate. The 
data was analyzed in RStudio (Free Software Foundation, Inc.) (see Figure 3.6). 
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2.5. Expression and purification of recombinant proteins 
2.5.1. Expression of recombinant proteins 
An expression vector, pET-28b(+) containing Bacteroides thetaiotaomicron 
tet(X2) (residues 11-388) was a generous gift from Dr. G. D. Wright (McMaster 
University, Canada). TetX2 was expressed and purified according to protocol modified 
from Yang et al. (2004) (Wangrong Yang, 2004) . Tet(X2) containing vector was 
transformed into E. coli BL21 (DE3) Star strain (Agilent Technologies, Incorporated, 
Santa Clara, California). Bacteria were cultured in an orbital shaking incubator at 37°C in 
2 x YT media (16g/L tryptone, lOg/L yeast extract and 5g/L NaCl) supplemented with 50 
(lg/ml kanamycin in 5L flasks with 2L of media at 225 Revolutions Per Minute (RPM). 
Cultures were grown until cells reached optical density of -0.8 at 600 nm when the 
temperature was reduced to 16°C and expression was induced with isopropyl (3-D-l-
thiogalactopyranoside to 0.5 mM final concentration. Bacteria were further incubated at 
16°C overnight at 225 RPM. Cells were harvested by centrifugation at 8000 x g for 10 
min, and the pellets were stored at -80°C. Frozen cells were thawed on ice and 
resuspended in approximately 150 mL of lysis buffer consisting of 20 mM Tris pH 8, 500 
mM NaCl, 1 mM phenylmethanesulfonyl fluoride and 0.2 mM P-mercaptoethanol. Cells 
were lysed by sonication and the lysate was centrifuged at 15,000 x g for 30 min to 
remove the cell debris. 
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2.5.2. Affinity chromatography 
The soluble fraction containing TetX2 was applied to a nickel chromatography 
column. The His*Bind® Resin (EMD Chemicals, San Diego, CA) was manually packed 
into a glass column and charged with 100 mM Nickel sulfate. Once the nickel charged 
resin settled, the column was washed with 5 column volumes (CV) of MiliQ water and 
equilibrated with at least 5 CVs of Buffer A (20mM Tris pH 8, 500mM NaCI, 1 mM 
phenylmethanesulfonyl fluoride and 0.2 mM P-mercaptoethanol). The protein was 
expressed with an N-terminal His6-tag. The polyhistidine has an affinity for divalent 
metals such as Nickel so it enabled immobilization of a protein onto a column. His6-
tagged-TetX2 was captured on charged resin that was washed with 5 CV of Buffer A. 
The protein of interest was eluted with imidazole containing Buffer B (20mM Tris pH 8, 
1M NaCI, 500mM imidazol, 1 mM phenylmethanesulfonyl fluoride and 0.2 mM (i-
mercaptoethanol). Fractions yellow in color were analyzed on a 15% sodium dodecyl 
sulfate polyacrylamide gel electrophoresis (SDS-PAGE) gel (Figure 2.2.A). An 
equimolar amount of exogenous FAD was added to the fractions containing TetX2 after 
each purification step. Pooled fractions were dialysed against 20 mM Tris pH 8, 100 mM 
NaCI, 1 mM phenylmethanesulfonyl fluoride and 0.2 mM P-mercaptoethanol, overnight. 
The N-terminal His6-tag was removed by digestion of TetX2 protein sample with 
Thrombin for 24 h at 4°C (EMD Chemicals, San Diego, CA). The TetX2 digest was 
analyzed on a 15% SDS-PAGE gel and applied on a Chromatography HisTrap™ HP 
column (GE Healthcare). The flow through and wash fractions were analyzed on a 15% 
SDS-PAGE gel (Figure 2.2.B), Fractions with cleaved His6-tag were pooled and dialyzed 
against 20 mM Tris pH 8, 100 
mM P-mercaptoethanol, and 1 
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mM NaCl, 0.2 mM phenylmethanesulfonyl fluoride, 5 mM 
mM EDTA, overnight. 
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Figure 2.2. Anion Exchange Chromatography of TetX2. 
A) Soluble fraction after cell lysis was collected and applied onto the Ni-NTA column, 
where His-tag-TetX2 was captured. B) The elute from this purification step (E4-E6) was 
then incubated overnight with thrombin to cleave the His-tag. Fractions were resolved on 
15% SDS-PAGE gel. 
2.5.3. Anion-exchange chromatography 
Ion exchange chromatography is a common method used to separate molecules 
based on their net charge. The theoretical isoelectric point of TetX2 was calculated using 
EXPASY proteomics server and was about 5.4 suggesting that at neutral pH the protein is 
negatively charged. Anion exchange chromatography was performed on AKTA fast 
protein liquid chromatography (FPLC) unit and Unicorn™ software. The protein sample 
was removed from dialysis tubing and filtered through 0.22 [xm syringe filter. The sample 
was then loaded onto a HiTrap Q Sepharose XL anion exchange chromatography 
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column. The column was pre-equilibrated with 5 CV of Buffer A (20 mM Tris, 100 mM 
NaCl, 0.2 mM phenylmethanesulfonyl fluoride, 5 mM (3-mercaptoethanol, and 1 mM 
EDTA, pH 8). The negatively charged protein bound to the positively charged resin and 
was washed with 2 CV of low salt Buffer A. A linear gradient of 0-1 M NaCl over 20 CV 
was applied onto the column to elute TetX2. Using high salt containing negatively 
charged chloride outcompetes positively charged protein from the column. Fractions 
containing yellow protein were analyzed on 15% SDS-PAGE gel (Figure 2.3.A), 
2.5.4. Size-exclusion chromatography 
Size exclusion chromatography is often used in protein purification to separate 
molecules based on their mass and hydrodynamic shape. The limitations of this approach 
are that the shape of the molecule affects how fast it travels in the column as well as the 
fact that molecules to be separated have to be at least twice the size from each other to be 
effectively separated. Following anion exchange chromatography, fractions containing 
TetX2 were pooled, concentrated to 2 mL total volume and loaded onto HiLoad 16/60 
Superdex-200 column (GE Healthcare) on the AKTA FPLC system. TetX2 was eluted as 
a single peak. Finally, yellow fractions were analyzed on 15% SDS-PAGE gel, were 
pooled and concentrated to final concentration of 15 mg/ml (Figure 2.3.B). Protein 
samples were flash frozen in liquid nitrogen and were stored at -80°C. The other TetX2 
mutants was expressed and purified as described above. 
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Figure 2.3. Anion Exchange and Size Exclusion Chromatography of TetX2. 
A) After overnight dialysis His-tag cleaved protein sample was applied onto Q-XL 
Sepharose column. Fraction 2-10 corresponding to the largest peak on the chromatogram 
were resolved on 15% SDS-PAGE gel. B) Fractions 3-7 from anion-exchange 
chromatography were pooled, concentrated and applied onto Superdex-200 size exclusion 
column. Fractions 5-10 were pooled, concentrated to 15 mg/ml and flash frozen in liquid 
nitrogen for storage at -80°C. 
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2.5.5. Expression and purification of Seleno-methionine labeled TetX2 
Seleno-methionine labeled TetX2 (SeMet-TetX2) was expressed according to the 
methionine inhibition pathway method (Doublie, 1997). The cell culture was grown in 
M9 Minimal media supplemented with 50 Jig/ml of kanamycin. Prior to induction of 
protein expression 50 mg/L of L-selenomethionine, 100 mg/L of leucine, isoleucine, 
phenylalanine, and 50 mg/L of threonine, lysine, valine were added to the media. The 
expression was carried out in the shaking incubator in the dark, overnight at 16°C. The 
SeMet-TetX2 was purified following the same steps as described above for the native 
protein. 
2.6. Measurement of kinetic parameters of TetX2 and its mutants at various 
minocycline concentrations 
Steady-state kinetic parameters were measured using a previously described, but 
modified TetX2 activity assay (Wangrong Yang, 2004). Changes in absorbance 
corresponding to MCN hydroxylation by TetX2 was monitored at 400 nm (£400= 12000 
M"1 cm"1) over 5 minutes in a Infinite® Ml000 plate reader (Tecan Group Ltd.) (Figure 
2.4). In order to determine the kinetic mechanism of TetX2, the steady-state kinetics 
parameters were measured at various MCN (0-400 |iM) and NADPH (12.5-200 |xM) 
concentrations at 37°C. Each reaction included 5 mM MgCl2, about 0.2 |j.M protein, 0-
400 [iM MCN and 12.5-200 piM NADPH in 20 mM Tris, pH 8.0. The assay was 
performed in triplicate. Steady-state kinetic parameters were determined by fitting initial 
reaction rates (u0) to binary complex mechanism equation 1 (Eq 4.3) (Figure 4.2) where 
[A] = MCN concentration, and [B] is NADPH concentration, using Prism (GraphPad). 
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Figure 2.4 Change in absorbance corresponding to minocycline degradation as a 
function of time. 
TetX2 actively degrades minocycline in the presence of Mg2+' oxygen and NADPH over 
20 minutes.. 
2.7. TetX2 activity from cell extracts 
In vivo TetX2 mediated inactivation of MCN was estimated from cell extracts 
prepared from each of the E. coli BW25113 cell lines expressing chromosomal copies of 
wild-type and mutant tetX2. Background levels of MCN inactivation activity were 
determined from extracts of BW25113 without tet(X2). Cells were grown in LB without 
MCN at 37°C and harvested by centrifugation at an OD -0.6-0.8 prior to lysis by 
sonication. The steady-state TetX2 activity for inactivation of MCN by the soluble crude 
extracts was assayed using the previously described in vitro assay. TetX2 activity was 
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measured at 25, 50 200 FIM MCN at 200 jiM of NAPDH. All measurements were done 
in triplicate. The total amount of protein in each cell lysate was estimated by Bradford 
assay to account for variability in the efficiency of cell lysis. Relative enzyme 
concentrations were calculated by fitting initial velocity measured at 200 fiM MCN using 
binary complex equation (to incorporate Km(mcn> and KM(NAdph), since the measurements 
were done under non-saturating conditions for some enzymes) (Eq. 4.1) (Figure 4.4), 
where Vmax=fccat[Eo], Eo=total enzyme concentration. 
2.8. Crystallization, Structure Determination and Refinement 
2.8.1. Crystallization and Data Collection 
The initial crystallization conditions for TetX2 were determined using the Hydra 
II Plus One robot and commercially available screens (Qiagen, Hampton) by Dr. Gang 
Wu. Further optimization of the crystallization conditions was carried by hand using a 
hanging and sitting drop vapor diffusion methods starting with conditions determined by 
the automated screening, which included 2.1 M Ammonium Sulfate, 2% (v/v) 
methylpentanediol, 0.1 M CHES pH 9.0 at 20 °C. Initially, only small crystals of TetX2 
were obtained, but by varying the precipitant concentrations, pH, and lowering the 
incubation temperature to 10 °C bigger crystal were grown within 3-7 days. These 
crystals had a tendency to form thin rods clustered in the center, however, through 
addition of additives such as ethanol, di-oxane, and glycerol, single long rod-like crystals 
were obtained under 1.8 M Ammonium Sulfate, 0.5% (v/v) ethanol or glycerol, 0.1 M 
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CHES pH 9.2 at 10 °C (Figure 2.5). SeMet-TetX2 crystals were obtained under similar 
crystallization conditions using the sitting-drop vapor diffusion method by Dr. Milya 
Davlieva. 
Figure 2.5. Optimization of TetX2 crystallization conditions. 
A) Initially, TetX2 crystals grew as tiny clusters. B) Lowering temperature resulted in 
larger rod-like crystal C) Additives, such as glycerol produced single, well shaped TetX2 
crystals. 
Diffraction data for the native TetX2 crystals were collected at our home source 
using a Rigaku R-AXIS IV++ detector (Figure 2.6). Multiple-wavelength anomalous 
dispersion (MAD) data were collected by Jay Nix at Advanced Light Source (ALS) 
beamline 4.2.2 using a NOIR-1 MBC detector. The native data were processed using 
d*TREK (Pflugrath, 1999) and the data collected on the SeMet-TetX2 crystals were 
processed using HKL2000 (Otwinowski, 1997) (Table 2.1). Native and SeMet-TetX2 
crystals diffracted to 2.5 A and 2.8 A, respectively. Both proteins crystallized in space 
group P2| with cell dimensions a = 87.65 A, b = 67.41 A, c = 152.35 A and angles a = (3 
= 90.0° and y= 101.68°. 
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Figure 2.6. Diffraction image of TetX2 native crystal collected on a home source X-
ray generator at Rice University with high resolution spots diffracting to 2.8 A. 
Structure factor data quality was analyzed using Phenix.Xtriage which indicated 
presence of an additional high intensity peak away from the origin (Adams et al., 2010). 
The summary of output is shown in Figure 2.7. A Native Patterson map was generated 
using xxft program from XtalView suite (McRee, 1999) . A significant off origin peak 
with intensity of 51.56% of the original peak was detected at position 0.5, 0.05 0.5 
(Figure 2.8). The significance of the peak is determined by the p-value which determines 
the probability of a peak of this intensity to occur by chance. The p-value for the native 
data set was very low (5.357E-05), indicating that the chance for the peak to occur 
randomly was very low. In addition, the intensity of the off-origin peak being half of the 
origin peak strongly implied that the non-crystallographic symmetry was pseudo 
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translational. Translational and pseudo-translational symmetry can often complicate the 
structure solution using either molecular replacement or multi-wavelength anomalous 
dispersion. This may explain why initial attempts in solving the structure by MR failed 
using Phaser. BALBES, which is known to handle pseudo-translational symmetry better 
than Phaser was used for structure solution (Long et al., 2008). 
Twinning and intensity statistics summary (acentric data): 
Statistics independent of twin laws 
- <IA2>/<I>A2 :2.862 
- <F>A2/<FA2> : 0.688 
- <|EA2-1|> : 0.895 
- <|L|>, <LA2>: 0.524, 0.359 
Multivariate Z score L-test: 3.405 
The multivariate Z score is a quality measure of the given 
spread in intensities. Good to reasonable data are expected 
to have a Z score lower than 3.5. 
Large values can indicate twinning, but small values do not 
necessarily exclude it. 
No (pseudolmerohedral twin laws were found. 
Patterson analyses 
- Largest peak height : 51.761 
(corresponding p value : 5.357e-05) 
The analyses of the Patterson function reveals a significant off-origin 
peak that is 51.76 % of the origin peak, indicating pseudo translational symmetry. 
The chance of finding a peak of this or larger height by random in a 
structure without pseudo translational symmetry is equal to the 5.3569e-05. 
The detected tranlational NCS is most likely also responsible for the elevated intensity ratio. 
See the relevant section of the logfile for more details. 
The results of the L-test indicate that the intensity statistics 
behave as expected. No twinning is suspected. 
Figure 2.7. Summary of data quality analysis for native P21 crystals by 
Phenix.Xtrage. 
Data analysis using Phenix.Xtriage showed that there is no pseudo merohedral twinning. 
A significant off-origin peak was detected at height corresponding to 51.76% of the 
origin peak indicating presence of pseudo translational symmetry. 
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2.8.2. Native TetX2 Structure Determination and Refinement 
The initial structure determination by molecular replacement (MR) was 
performed using BALBES (Long et al., 2008). The best solution was obtained when PhzS 
from Psedomonas auerugosa (PDBID:3c96) was used as a search model (21% sequence 
identity). The solution from the MR model suggested four molecules in the asymmetric 
unit. The arrangement of the molecules in the asymmetric unit is shown in Figure 2.9. 
The asymmetric unit consists of two pairs of dimers related by 2-fold non-
crystallographic symmetry (AC:BD). The matrices describing how to go from one dimer 
to the other is shown below: 
Rotation: 
r={-0.99986, 0.01632,-0.00239} 
{ 0.01630, 0.99985, 0.00607} 
{ 0.00248, 0.00603,-0.99998} 
Translation: 
t={31.00092}, {28.49513}, {75.90825} 
The initial model was submitted to phenix.autobuild and phenix.refine for 
automatic building and structure refinement (Adams et al. 2010). Diffraction data 
collected at the peak wavelength 0.97889 A were used for structure determination by 
Single-wavelength anomalous dispersion (SAD) using phenix.autosol (Adams et al. 
2010). The partial model obtained by MR was used to search for Se sites. Automated 
model building by phenix.autobuild (Adams et al. 2010) resulted in successful placement 
of -55-60% of the protein structure with the initial R-factor = 45% and R-free = 47.5%. 
The model was further built manually in COOT (Emsley and Cowtan, 2004) and refined 
by phenix.refine. The initial refinement strategy included rigid-body, positional and 
group ADP refinement with non-crystallographic symmetry (NCS) restraints. FAD was 
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fit manually into an unoccupied density found in all 4 molecules. Additionally, TLS 
refinement was carried out in phenix.refine (Adams et al. 2010). An anisotropy 
correction applied to SAD data set resulted in a 2% drop in R-factor and R-free after 
refinement (Strong et al., 2006). Data collection summary and refinement statistics are 
summarized in Table 2.1. Structure coordinates were deposited in the Protein Data Bank 
under accession number 3P9U. 
Figure 2.9. Arrangement of TetX2 molecules in the asymmetric unit. 
The asymmetric unit is composed of two pairs of dimers (AC-BD) related by 2-fold non-
crystallographic symmetry. The rotation and translation matrices to go from one dimer to 
the other are shown above. 
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Table 2.1. Summary of Data Collection and Reflnement Statistics for TetX2 
Data Collection SeMet TetX2 
Wavelength (A) 
Resolution (A)a 
Space group 
Unit Cell (A) 
Total number of reflections3 
Unique reflections 
Average redundancy3 
Completeness (%)a 
R merge (%) a,b 
Output <I/sigI> 
Refinement 
0.97889 
50 - 2.80 (2.85 - 2.80) 
P2, 
a = 87.70, b = 67.33, c = 153.79 
a = y = 90.0°,P= 100.31° 
132098 
39866 
3.3 (3.2) 
92.0 (86.7) 
11.8 (28.6) 
16 (3.9) 
Rwork (%f 
Rfree (%)d 
r.m.s.d.e from ideality 
Bonds(A) 
Angles (°) 
Average B-factor (A2) 
Ramachandran* 
favored (%) 
additional allowed (%) 
disallowed (%) 
PDB accession number 
24.00 
28.24 
0.009 
1.255 
25.05 
92.1 
7.9 
0 
3P9U 
"Values for the last shell are in parentheses. 
bRnierge £ |I - <I> |/ Y, I. where I is measured intensity for reflections with indices of hkl. 
cRwork X |Fo - Fc| / Z |F<>I for all data with F0 > 2 a (Fc) excluding data to calculate Rfree. 
dRfree Z |Fo - Fcl IZ |Fol for all data with F0 > 2 o (F0) excluded from refinement. 
eRoot mean square deviation. 
Calculated by using MolProbity 
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2.8.3. Structure Determination and Refinement of TetX2 in Complex with 
Minocycline and Tigecycline 
Crystallization of TetX2r280A was performed under similar conditions to the wild-
type TetX2 described before using vapor diffusion sitting-drop method (Walkiewicz et 
al., 2011). Native crystals were soaked in various MCN and Tigecycline concentrations 
for 16 hours prior to cryoprotection. Crystals were cryoprotected in 25% (v/v) glycerol 
and immediately flash frozen in liquid nitrogen. Single wavelength data were collected 
by Jay Nixat the Advanced Light Source beamline 4.2.2 using a NOIR 1 MBC detector. 
2.8.3.1. TetX2:MCN complex: 
The diffraction data for TetX2:MCN complex crystals were processed using 
HKL2000 software in space group PI to 2.7A resolution (Otwinowski, 1997). The 
initial structure determination by molecular replacement (MR) was performed using 
phenix.autosol (Adams et al., 2010) with wild-type TetX2 structure, omitting FAD 
cofactor as a search model [Protein Data Bank (PDB) ID: 3P9U]. Based on the initial MR 
solution, four molecules were positioned in the asymmetric unit. The initial model was 
submitted for automated building and refinement to phenix.autobuild and phenix.refine 
(Adams et al., 2010), respectively. Automated model building and refinement resulted in 
Rwork=24.1% and Rfree=30.1%. The electron density for flavin adenine dinucleotide 
(FAD) was visible in all four molecules in the asymmetric unit. FAD was built manually 
in COOT (Emsley and Cowtan, 2004) and was used in the refinement of the structure. In 
addition, unoccupied electron density corresponding to MCN molecules was identified 
near the FAD isoalloxazine ring in the composite omit map generated in PHENIX 
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(Adams et al., 2010). MCN molecules were fitted manually in COOT and were included 
in final stages of refinement. Data collection and refinement statistics are shown in Table 
2.2. Structure coordinates were deposited in the PDB under accession number 3V3N. 
2.8.3.2. TetX2:tigecycline complex 
The strategy used for structure solution of TetX2:tigecycline complex closely 
resembled the one followed for TetX2:MCN complex. The diffraction data were 
processed using HKL2000 software in space group PI to 2.9A resolution (Otwinowski, 
1997). The initial structure determination by MR was performed using phenix.autosol 
(Adams et al., 2010) with the same initial search model [Protein Data Bank (PDB) ID: 
3P9U], Similarly, four molecules were positioned in the asymmetric unit and the initial 
model was submitted for automated building and refinement. The monomers in the 
asymmetric unit are related by 2-fold non-crystallographic symmetry axis. Automated 
model building and refinement resulted in Rwork=26.3% and Rfree=33.7%. The electron 
density for flavin adenine dinucleotide (FAD) was visible in all four molecules in the 
asymmetric unit. FAD was built manually in COOT (Emsley and Cowtan, 2004) and was 
used in the refinement of the structure. The electron density for tigecycline was visible in 
copies A and C and was weaker in copies D and B based on the (2Fo-Fc) SIGMAA 
weighted composite omit map. The electron density for the aliphatic chain of tigecycline 
was visible only in copy A. Tigecycline molecules were fitted manually in COOT and 
were included in final stages of refinement. Data collection and refinement statistics are 
shown in Table 2.2. Structure coordinates were deposited in the PDB under accession 
number 3V30. 
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Table 2.2. Summary of Data Collection and Refinement Statistics 
Data Collection TetX2T280A • MCN TetX2t280A : TIG 
Wavelength (A) 1.00004 1.00004 
Resolution (A)a 49.3 - 2.70 (2.70 - 2.60) 48.94 - 2.90 (2.98 - 2.90) 
Space group PI PI 
Unit Cell (A) a = 68.43, b = 80.10, c = 87.36 a = 68.13, b = 80.08, c = 87.24 
a = 111.11° p =90.10° y = a = 111.02° P =89.97° y = 
93.01° 92.97° 
Total number of reflections" 72314 72992 
Unique reflections 41120 40388 
Average redundancy3 1.7 (1.5) 1.8 (1.7) 
R merge (%?* 7.4 (31.7) 10.2 (35.8) 
Output <I/sigI>a 16.1 (2.0) 14.6 (1.96) 
Refinement 
Rwork (%)Q 22.08 23.73 
Rfree (%)d 27.57 29.00 
r.m.s.d.e from ideality 
Bonds(A) 0.009 0.01 
Angles (°) 1.235 1.46 
Average B-factor (A2) 50.60 68.78 
Ramachandranf 
favored (%) 93.47 95.5 
outliers (%) 0.28 0 
PDB accession number 3V3N 3V30 
'Values for the last shell are in parentheses. 
hRnictge XI'- <I> I' X '• where I is measured intensity for reflections with indices of hkl. 
'R.„i X |K, - Fj / X |f*«l f°r a'l data with F„ > 2 a (F„) excluding data to calculate 
X |F„ - HL|/ X |F.>I for a" data with F„ > 2 a (F„) excluded from refinement. 
Hoot mean square deviation. 
'Calculated by using MolProbity 
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2.9. Construction of directed evolution mutant library 
The single point mutational library was generated using a commercially available 
GeneMorphll Random Mutagenesis Kit® (Agilent Technologies). The mutational rate 
was adjusted by varying the template concentrations in the PCR. The target mutational 
rate for the library of 1-2 single point mutations per gene was achieved when 20 ng of a 
template (te/(X2)/pUC19) was used in each reaction (Figure 2.10). Mutated tetX2 PCR 
products were ligated into a pUC19 backbone, behind a constitutively active lacZ 
promoter. The ligation products were transformed into E. coli DH10B cells and plated on 
100 |ig/ml of ampicillin to estimate the library size and mutational rate. Screening for 
active mutants was performed on LB-agar plates containing 4 |xg/ml of MCN. Plasmid 
DNA from 35 colonies was isolated and sent for sequencing of tetX2 gene. 
Lac-Z 
TetX/pUC19 
3799 bp 
Figure 2.10. Architecture of tetX2/pUC19 vector. 
The library mutants of tetX2 were cloned into a pUC19 backbone behind a constrictive 
promoter lacZ between restriction sites BamHI and EcoRI. 
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2.10. Circular Dichroism (CD) 
CD experiments were performed using a Jasco J-815 spectrophotometer. Spectra 
were recorded at 200 - 250 nm at 20°C. The thermal stability of TetX2 and the mutant 
TetX2T280A was determined by monitoring absorption at 220 nm at the temperature range 
20°C - 90°C using a scanning rate of 607hour in triplicate. Protein samples were 
prepared to the concentration of 20 |liM in 20 mM Tris, pH 8.0. The thermal unfolding 
midpoint (Tm) could only be approximated as protein denaturation was largely 
irreversible. 
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Chapter 3 Adaptation of TetX2 
The objective of this project is to discover the biophysical principles that govern 
adaptation of naturally evolved Escherichia coli strains to tetracycline antibiotics and 
develop a model that can predict the successful evolutionary trajectories to TetX2 
mediated resistance. We combined experimental evolution with in vitro error-prone 
mutagenesis to explore all potential single point mutations of TetX2 that could be 
candidates for natural selection and identify which physicochemical properties are most 
correlated to fitness in a population. 
3.1. Experimental evolution of E. coli expressing a chromosomal copy of tet(X2) 
Wild-type tet(X2) was chromosomally integrated into the spc operon of E. coli 
BW25113 between prlA (SecY) and rpmJ (L36) by recombineering, to produce a strain 
(BW25113iet(X2)) carrying a single copy of tet(X2) under expression of the endogenous 
spc promoter. Chromosomal integration of tet(X2) eliminated concerns of variable gene 
copy numbers that can complicate interpretation of results. Confirmation PCR was 
performed using genomic DNA isolated from colonies recovered from tetracycline (10 
|ig/ml) LB-agar plates and confirmed by DNA sequencing. The minimum inhibitory 
concentrations (MIC) values towards MCN for the wild-type BW25113 strain and 
BW25113tel(X2) were measured to be at 2 and 16 (ig/ml, respectively. Based on the MIC 
values, 10 |lg/ml of MCN, a concentration that allowed growth of E. coli BW25513 lel(x2) 
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during a twelve hour period was set as a starting condition for the serial-passage 
experiment. 
Serial-passage of E. coli (BW25113tet(X2)) grown in shaking flasks to gradually 
increasing MCN concentrations from 10 to 320 Jig/ml was performed over 10 days at 
37°C in LB (Figure 3.1). 
MIC 
Serial-passage experiment 
[minocycline] 
Day 
0 
Day 
<3 
Day 
A 
Day 
C lb 
16 pg/ml , : 24 Mg/ml , 
4 
, 36 Mg/ml ; 
D 
52 |jg/ml 
1 1 1 1 
O O O O 
O o o o 
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Minocycline 
Figure 3.1. Adaptation to minocycline experiment. 
E. coli with tetracycline resistant gene (tetX2) were subjected to increasing antibiotic 
concentrations (10-320 |ig/ml) over 10 days. Each day, 50 (ill of cells were transferred to 
fresh media with higher minocycline concentrations. Samples from each day were pooled 
and stored at -80°C. The tet(X2) gene was PCR amplified from colonies showing 
increased antibiotic resistance and the tet(X2) gene was sequenced. 
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DNA sequencing analysis of the tet(X2) allele from colonies isolated on different 
days of the experiment identified a single missense mutation (Thr to Ala) at position 280 
on day 2, when MCN concentration in the media was 16 |ig/ml (32 (iM). 
In order to determine the effect of Thr to Ala substitution in TetX2 on the overall 
resistance of the organism, this mutation was reintroduced chromosomally into the naive 
BW25113-tet(X2) strain that had not been exposed to antibiotics and the MIC remeasured 
at 37°C (Figure 2.1). The unadapted strain with tet(X2}hsoa (BW2511?>-tet(X2hm)\) 
showed the expected increase in MIC to MCN at 37°C from 16 to 64 Hg/ml (Table 3.1, 
Figure 3.2). 
This increase in MIC is in good agreement with the selection conditions used on 
day 2 of the serial passage experiment. The MICs toward tetracycline and tigecycline 
were also determined for BW251 \3-tet(X2)-nmA and showed a comparable increase in 
resistance towards both antibiotics (Table 3.1, Figure 3.3) although neither drug was 
included during the serial-passage suggesting general expansion in the range of 
tetracyclines. 
Table 3.1. Minimum Inhibitory Concentration (MIC)8 of strains isolated 
during experimental evolution to tetracycline antibioticsb. 
BW25113 BW25113 BW25113 BW25113 
tet(X2) tetX2 j2koa tetX2j2soA 
Day 9 
Tetracycline 4 128 >128 >128 
Minocycline 4 16 64 >128 
Tigecycline 1 8 16 >128 
aMIC determined by agar-dilution method according to NCCLS guidelines 
b Drug concentrations in (J.g/ml 
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TetX2 wt TetX2 T280A 
0 ng/ml 
2 jag/ml 
4 ng/ml 
8 |ug/ml 
16 (.tg/ml 
32 |.ig/ml 
64 f.ig/ml 
128 ng/ml 
AS 
Figure 3.2. Adaptive mutant of tet(X2)r2S0A isolated through experimental evolution 
has increased resistance to MCN by 4-fold at 37°C. 
MICs to MCN were measured by agar dilution test (see section 2.3 for methods) for three 
individual colonies from E. coli (BW25113) strains expressing either tet(X2) or 
tet(X2)-nsoA- Growth of E. coli BW25113-tet(X2) was inhibited at 16 mg/ml and E. coli 
BW251 \ 3-tet(X2)j2mA showed no growth only at 64 mg/ml, suggesting that the T280A 
mutation alone is sufficient for a 4-fold increase in the MIC for MCN. 
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Figure 3.3. Adaptive mutant of tet(X2)n80A has increased resistance to MCN and 
tigecycline. 
The MICs measured by E-test for E. coli strains expressing tet(X2) or tet(X2)j2»0A show 
an increase in resistance (smaller inhibition zone) for both MCN (top panel) and 
tigecycline (lower panel), even though the cells were not exposed to tigecycline 
previously. This suggests that the adaptive mutation has broadened the specificity of the 
enzyme (see section 2.3 for methods). 
T280A was the only mutation in tet(X2) identified during the experiment, 
although, resistance to MCN continued to increase beyond 320 p.g/ml. These results 
suggest that an approximately 20 fold increase in resistance is a result of both changes 
within the tet(X2) gene as well as the E. coli chromosome. 
In addition, we tested, whether E. coli BW25113 alone (without tetX2) could 
adapt to higher MCN concentrations. We determined that E. coli BW25113 could not be 
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readily adapted beyond an MIC of 4 Hg/ml to MCN without having either a 
chromosomally expressed copy of tet(X2), a multicopy plasmid expressing tet(X2) or 
another tetracycline resistance gene such as TetA on pBR322 (Figure 3.4) These findings 
are consistent with other studies suggesting a more limited ability for many E. coli strains 
to adapt to tetracyclines in the absence of horizontal gene transfer (Viveiros et al., 2007; 
Zhang et al., 2008). Our results suggest that tet(X2) expression plays an important role in 
facilitating adaptation to very high MICs. It is unclear how tet(X2) may mediate or 
interact with these later chromosomal changes to raise resistance. The inability of the 
strain without tet(X2) to adapt suggest that there is a substantial epistasis between tet(X2) 
and the chromosomal changes. 
• ADAPTED 
NoTetX TetX 
Figure 3.4. Adaptation of E. coli BW25113 to high MCN concentration is highly 
dependent on expression of tet(X2). 
The MIC of E. coli expressing tet(X2) increases from 16 |lg/ml to < 320 |ig/ml over the 
course of 10 days. E. coli without tet(X2) have an MIC of 4 fig/ml and don't have the 
ability to adapt to MCN unless tet(X2) or other tetracycline resistance determinant is 
present. 
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Serial passage of the highly resistant strain for 6 days in the absence of antibiotic 
showed no decrease in MIC, consistent with genomic changes rather than transient 
changes attributed to gene expression, suggesting an important role for chromosomal 
changes outside tet(X2) in adaptation. 
3.2. In vitro evolution of TetX2 
TetX2x280A> a mutant with increased resistance to MCN, was the only TetX2 
variant identified by experimental evolution. Based on these results, we asked whether 
T280A was the only single-point mutation of TetX2 that had a potential for success under 
selection towards MCN, or were there other single-point mutations that confer equal or 
greater resistance than the wild-type enzyme? To answer this question, we used in vitro 
error prone mutagenesis to construct a library of all the adaptive TetX2 single nucleotide 
polymorphisms (SNPs) that could serve as likely candidates for natural selection in a 
bacterial population undergoing adaptation to increasing MCN concentrations. 
3.2.1. Characterization of the error-prone library 
In order to generate a library with mutational rate between 1-2 single point 
mutations per gene, the template (TetX2/pUC19) concentration was adjusted to 20 ng 
for each round of error prone PCR. Prior to selection, we estimated that in order to 
sample 95% of all possible single-point mutants, a library of 10,000-15,000 transformants 
had to be made and subjected to selection at drug concentration at which tet(X2)wiid- lype 
formed colonies within 24 hours. To estimate library size, the library was initially plated 
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on ampicillin. Based on the number of colonies counted (2x106cfu/ml), we estimated that 
this library had an eight-fold coverage of the minimum requirement. We felt confident 
that all possible single mutations were most likely to be sampled in the experiment. 
Results obtained from sequencing data based on plasmid DNA isolated from colonies 
selected for on ampicillin plates determined the mutational rate of the library to be 1.37 
mutations/kB (see section 2.9). The distribution of mutations in the library is shown in 
Figure 3.5. 
10-i 
Number of mutations per tetX2 gene 
Figure 3.5 Distribution of mutations in the error-prone library of tet(X2) mutants. 
The average mutation rate of tet(X2) library was estimated at 1.37 mutations per kb. Most 
sequences contained zero or one mutation in tet(X2) gene. 
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3.2.2. Identification of functional TetX2 mutants 
Selection for functional mutants expressed from a plasmid in a sensitive E. coli 
strain was performed on LB-agar plates containing 4 (ig/ml of MCN, corresponding to 
the concentration of the drug at which both wild-type tet(X2) and tet(X2)nmA are able to 
sustain growth over 24 hours at 37°C. 
Seven adaptive mutants were identified that had MIC to MCN equal to, or greater 
than, tet(X2)WM.type (Table 3.2) and included tet(X2)t28oa, the mutant identified 
previously by experimental evolution. Two out of the seven mutations, (T280A and 
K64R) arose from an A to G transition, while the remaining five mutations were the 
result of transversions. In addition, two sets of the mutations occurred at the same 
position in the protein sequence and included pairs T280A and T280S, as well as N371T 
and N371I. 
Table 3.2. Mutations recovered from error prone PCR generated library 
Mutation site DNA MICMCN" Transition/ 
I ransversion 
WT N/A 16 N/A 
K64R AAA-A(IA 24 Transition 
F235Y TIT - TAT 32 Transversion 
T280A ACG-(;CG 64 Transition 
T280S ACG-TCG 16 Transversion 
S326I ACT-AIT 32 Transversion 
N371T AAC -AT'C 64 Transversion 
N371I AAC - ATC 64 Transversion 
a MIC values were determined by E-test and are reported in (ig/ml of MCN. 
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3.3. Fitness of adaptive mutants based on in vivo growth rates as a function of 
MCN concentration 
Success of newly arising mutations in an evolving population strongly depends on 
the fitness benefit conferred by the mutations under selective environment. Because 
adaptive mutations of TetX2 have different effects on bacterial fitness when challenged 
with a range of MCN concentrations, MIC tests are not appropriate to assess their fitness 
in vivo. For example, the ability to form a colony after 24 hours is a poor quantitative 
measure of growth rate. Likewise, growth overnight in a liquid culture is also a very poor 
metric. Here, we use growth rate assays as a direct measurement of fitness because they 
provide more accurate link between physicochemical properties of TetX2 and bacterial 
growth than MICs. 
Each mutant allele was introduced into the chromosome by recombineering 
performed following a protocol described for the generation of E.coli BW25113-
tet(X2)vliid-type strain. The growth rates were measured for all eight E. coli strains, each 
with a chromosomal copy of a different tet(X2) allele, over a range of MCN 
concentrations (Figure 3.6, Table 3.4, section 2.4) that correspond to FDA guidelines for 
the susceptibility testing of Enterobacteria at 37°C (www.accessdata.fda.gov). The 
breakpoint for resistance to MCN is 16 Hg/ml (32 fiM) and 4 ^ig/ml (8 |iM) for 
susceptible strains. 
Relative to the ancestral BW25113 strain, E.coli expressing either wild-type 
tet(X2) or a candidate tet(X2) mutant had equal growth rates within experimental error in 
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the absence of MCN, indicating that all strains had nearly identical fitness under non­
selective conditions (Table 3.3). 
Table 3. 3. Growth ratesa'b of E.coli BW25113 and the adaptive tet(X2) strains in the 
absence of antibiotics. 
BW25113 TetX2 T280A N371I N371T S326I F235Y K64R T280S 
0.013 0.013 0.012 0.012 0.012 0.013 0.013 0.013 0.012 
"Growth rates presented in the table have not been normalized and represent raw data 
bErrors in the measurements were < 0.001 
As expected, MCN had the most dramatic effect on the growth of the ancestral 
strain, since it did not have a tetracycline resistant determinant, showing 40% decrease in 
growth at 4.1 fiM (2 |ig/ml) MCN. Beyond 24.3 p,M (8 H-g/ml), the growth of the 
ancestral strain was not detected. Two strains expressing tet(X2)n8os and tet(X2)K64R 
exhibited slower growth rates at approximately 12 (iM (4 |ig/ml) MCN, in comparison to 
the rest of the adaptive mutants (0.73 ± 0.03, 0.69 ± 0.03, respectively) and their growths 
were completely inhibited beyond 40 ^M MCN. The performance of these mutants was 
very similar to wild-type tet(X2), suggesting that both point mutations did not have 
significant effect on the function of the wild-type enzyme. 
Two strains carrying tet(X2)F235Y and tet(X2)s.mi exhibited intermediate fitness 
when compared the most successful mutants. For example, growth rates of both 
tet(X2)y235Y (0.58 ± 0.01) and tet(X2)s.mi (0.54 ± 0.01) were approximately 40% lower 
than that of tet(X2)t2soa (0.92 ± 0.02) at 32 fiM MCN. Compared to the strain expressing 
wild-type tet(X2), the growth rate advantage of these mutations was over 300%, which 
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strongly suggests that these mutations had a significant effect on the in vivo function of 
the enzyme. 
Strain BW251 \3tet(X2)N^iTshowed greater resistance toward MCN exhibiting a 
significant 4-fold increase in growth rate when compared to the wild-type tet(X2). 
Finally, the most successful mutations tet(X2)r2K0A, tet(X2)Nuu had nearly 
indistinguishable growth rates at lower MCN concentrations < 40 }lM (20 fig/ml) where 
MCN would be employed clinically. A similar five-fold increase in growth rates for 
strains carrying these most resistant mutations implies that tet(X2)r2H0A and tet(X2)N^u 
have the largest effect on the kinetics of the enzyme. In addition, these results suggest 
that both mutants would have comparable success in a population during selection at 
concentrations where Tet(X2)nmA was identified (Figure 3.6). 
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Table 3.4. Relative growth rates" of ancestral strain and E. coli expressing chromosomal copies of wild-type and adaptive mutations. 
MCN 
(HM) 
Ancestor 
E.coUbv/isih TetX2 TetX2j2«0A TetX2N37n TetX2N371T TetX2S326i TetX2F2jsY TetX2R64R TetX2r28os 
0 1.00 ±0.01 1.00 ±0.01 1.00 ±0.01 1.00 ±0.01 1.00 ±0.01 1.00 ±0.04 1.00 ±0.03 1.00 ±0.03 1.00 ±0.02 
4.1 0.59 ±0.01 1.01 ±0.01 0.97 ±0.01 0.98 ±0.01 0.98 ±0.01 0.95 ±0.01 0.95 ±0.01 0.97 ±0.01 1.00 ±0.01 
8.1 0.39 ±0.01 0.94 ± 0.03 0.99 ±0.01 0.99 ±0.01 0.98 ±0.01 0.95 ±0.01 0.96 ±0.01 0.91 ±0.05 0.92 ± 0.05 
12.2 0.24 ±0.01 0.73 ±0.03 1.00 ±0.01 0.99 ±0.01 0.98 ±0.01 0.93 ± 0.02 0.94 ±0.01 0.69 ± 0.03 0.73 ± 0.03 
16.2 0.09 ± 0.05 0.56 ± 0.03 1.00 ±0.01 0.99 ±0.01 0.96 ±0.01 0.87 ± 0.02 0.85 ± 0.03 0.49 ± 0.03 0.52 ± 0.02 
20.3 0.04 ±0.01 0.41 ±0.01 1.00 ±0.02 0.97 ± 0.07 0.95 ± 0.07 0.79 ± 0.02 0.77 ± 0.02 0.29 ± 0.02 0.30 ± 0.02 
24.3 ND 0.27 ±0.01 1.00 ±0.01 0.95 ± 0.04 0.87 ± 0.04 0.70 ± 0.02 0.67 ± 0.02 0.20 ±0.01 0.21 ±0.02 
28.4 ND 0.16 ±0.01 0.93 ± 0.03 0.89 ± 0.02 0.73 ± 0.02 0.58 ±0.01 0.55 ±0.01 0.12 ±0.01 0.12 ±0.02 
32.4 ND 0.17 ±0.01 0.92 ± 0.02 0.89 ±0.01 0.75 ±0.01 0.58 ±0.01 0.54 ±0.01 0.12 ±0.01 0.11 ±0.02 
40.6 ND 0.09 + 0.01 0.78 ± 0.04 0.77 ±0.01 0.62 ±0.01 0.44 ±0.01 0.40 ±0.01 0.07 ±0.01 0.06 + 0.01 
60.8 ND ND 0.37 ± 0.05 0.55 ±0.01 0.34 ±0.01 0.20 ±0.01 0.16 ±0.01 ND ND 
101.4 ND ND 0.07 ± 0.04 0.23 ± 0.02 0.12 ±0.02 0.10 ±0.02 0.03 ± 0.02 ND ND 
' Growth rates in the table are normalized for each strain tested to the growth rate determined at 0|iM MCN. 
ND = growth not detected 
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Figure 3.6. Similar growth rate profiles for T280A and N371I suggest that both 
mutants should have equal opportunities for success in the evolution experiment. 
Growth of the ancestral strain E. coli BW25113 (no tet(X2)), strains with chromosomal 
copy of tet(X2)wiid-type and seven variants were monitored at OD^ for 24 hours. Growth 
rates determined at various MCN concentrations were plotted against the MCN 
concentrations (0-102 |iM). The experiment was repeated for three individual colonies 
represented by error bars corresponding to the standard deviation between the 
measurements. At lower MCN concentrations, growth rates for all the variants are 
comparable, suggesting that all the variants have equivalent fitness. Under conditions 
where T280A was selected for (32 (iM), the growth rates of N371I and T280A are nearly 
identical, while the growth rates of T280S and K64R are significantly lower and resemble 
the growth of wild-type TetX2. Growth rates (r) of each mutant at different MCN 
concentrations were normalized to its growth rate in the absence of MCN (r0). 
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3.4. Comparison of lag times for the adaptive mutants during growth at various 
MCN concentrations. 
Serial passage of populations in flasks allows for changes in fitness that occur 
from an ability to exit stationary phase. The faster an organism enters the log phase, the 
greater advantage it will have in an evolving population where millions of cells compete 
for success. In order to determine how much time was required for each strain carrying an 
adaptive mutant to begin exponential growth, we compared the lag times of each of the 
strains at various MCN concentrations (Figure 3.7). 
Relative to a stain carrying the wild-type allele, all mutants had indistinguishable 
lag times at low MCN concentrations, which is consistent with similar growth rates at 
those MCN concentrations. Similarly to the wild-type, strains expressing tet(X2)j-2sos and 
tet(X2)K64R experienced extended lag times starting at >20 jlM MCN. At 60 ^M MCN, 
the time to enter exponential phase began to increase for all strains carrying mutant 
alleles that conferred higher resistance to MCN. At 32 |iM MCN, which is the 
concentration of MCN at which T280A mutation was first observed, the lag time of 
strains carrying tet(X2)F235Y, tet(X2)s.mi and tet(X2)Nj7rr. tet(X2)Ni7n and tet(X2)r2H0A were 
identical. These data suggest that the mutants exhibiting higher resistance toward MCN 
show very similar growth patterns regarding their lag times at higher antibiotic 
concentrations. 
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Figure 3.7. Mutant strains of tet(X2) conferring higher resistance show similar lag 
time profiles at various MCN concentrations. 
The growth of E.coli strains with chromosomal copy of tet(X2)WM-iype and seven adaptive 
variants were monitored at OD600 for 24 hours. In addition to determination of growth 
rates (Figure 3.4) at various MCN concentrations, lag times of each mutant strain was 
estimated. The lag time described the time that it takes for bacteria to come out of lag 
phase and enter into log phase. The results were plotted against wide range of MCN 
concentrations (0-102 |i.M). The experiment was repeated for three individual colonies 
represented by error bars corresponding to the standard deviation between the 
measurements. At lower MCN concentrations, all variants take an equal amount of time 
to exit from the lag phase, which is in agreement with the growth rates data at low MCN 
concentrations. The differences in lag times are most apparent at higher MCN 
concentrations (>60 ^.M MCN). 
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3.5. Conclusions 
E. coli carrying chromosomal copy of tet(X2) showed a dramatic ability to adapt 
to very high MCN concentrations in a small number of generations. Changes within both 
tet(X2) gene, as well as the E. coli chromosome contributed to the nearly 20 fold increase 
in resistance and were critical for the adaptation to such high MCN concentrations since 
the strain lacking tet(X2) did not evolve higher resistance using even much weaker 
selections (a more gradual increase in MCN concentration). There results strongly imply 
that tet(X2) confers increased resistance that is highly epistatic with chromosomally 
encoded genes and suggests that tetr alleles may also facilitate adaptation through other 
genes on the chromosome. The observation that tet(X2) was required to reach the highest 
level of resistance was surprising since it is clear that the E. coli have the ability to move 
from MICs of 64 to 320 Hg/ml but do not seem able to make the initial adaptation from 
16-64 |lg/ml without TetX2 or TetA. In another strain of E. coli, Viveiros et al. showed 
that 110 days of slow adaptation was required to select for even modest resistance to 
tetracycline (Viveiros et al., 2005). It may be that tet(X2) and other tetr (TetA or TetM) 
alleles may be strong potentiators for higher resistance as well as directly conferring 
increased resistance. Although, we have shown that under laboratory settings, bacteria 
can evolve very high resistance, the goal of this study is to remain within the most 
clinically relevant settings. Therefore, the focus for the remainder of this study is to 
identify mechanisms that play a role in the initial adaption steps. 
The success of the adaptive mutants generated by error-prone mutagenesis was 
assessed by the growth assays at clinically relevant MCN concentrations. Based on the 
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performance at various MCN concentrations, the mutants can be divided into three 
groups: weak (wild-type like), intermediate and strong. Weak mutants included 
tet(X2)K64R and tet(X2)-nsos, which behaved very similarly to the wild-type tet(X2) at all 
MCN concentrations tested. The analysis of the fastest growth rates and the time each 
strains spent in the lag phase revealed that four mutants; tet(X2)miu, tet(X2) 
tet(X2)F235Y and tet(X2)S2m, in addition to tet(X2)t2hoa exhibited increases in growth rates 
at moderate MCN concentrations (Figure 3.6 and 3.7). Mutants with the strongest 
effects on growth rates compared to the wild-type strain included tet(X2)mi\\ and 
tet(X2)n37)T, with tet(X2)miu exhibiting the same growth profile as tet(X2)nm\- We did 
not identify any single-point mutants that had greater resistance than tet(X2)j2m\-
The fitness advantages of strains carrying tet(X2)n3?n and tet(X2)t2soa in the 
presence of MCN strongly suggest that both alleles had equal chances for success in the 
adaption experiment. Thus, it is puzzling that even though both tet(X2)nH0A and 
tet(X2)w7ii had identical growth rates at concentrations where te((X2)r2soA was isolated, 
(32 |iM) yet we did not recover any isolates carrying tet(X2)M7ii by experimental 
evolution. Is it simply not being made or does it appear but at much lower frequency, so 
it was not detected by sequencing because of a small sample size? 
There are three likely scenarios that might have played a role in the evolutionary 
dynamics. One possibility is that TetX2T280A is a better enzyme at low MCN 
concentrations and as a result has an advantage over TetX2N37n early on in the adaption 
experiment (growth rates of tet(X2)r280A are not affected by MCN up to approximately 
24 (0.M). It should also be noted that as MCN concentrations increase TetX2N37n should 
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have had a significant advantage over TetX2j280A, however at higher MCN 
concentrations changes in the chromosome contribute to the increase in resistance. 
Additionally, clonal interference and/or introduction of a bottle neck during daily 
transfer could have had a major influence on the evolutionary outcomes in the population. 
Clonal interference is common in asexually reproducing populations and occurs when 
beneficial mutation arise independently in different individuals (Elena and Lenski, 2003). 
As a result, clones carrying these beneficial mutations will compete and therefore inhibit 
each others' spread in a population. This often results in a loss of one of the mutations. In 
addition, the consequences of clonal interference are that the rates of spread of the 
beneficial mutation are much slower than predicted by the fitness benefit of a particular 
mutation in a clonal population (Gerrish and Lenski, 1998). Because of the similarity in 
fitness conferred by tet(X2)T2»oa and tet(X2)xn\Tn their proportions within the population 
relative to one another will not change at low drug concentrations. However, if there is an 
initial bias related to mutational frequency, this bias will remain until a significant fitness 
difference is achieved by the less frequent genotype. 
The reason for that initial bias in the E. coli population could be that mutation T280A 
results from a transition (ACG —>GCG) whereas N371I and N371T were both a result of 
transversion (AAC—•ATC, AAC—>ACC, respectively). As mentioned briefly in the 
introduction, mutations arising from transitions are more common than transversions 
(Bulmer, 1986; Vogel and Rohrborn, 1966; Wielgoss et al., 2011). This phenomenon in 
evolutionary biology is called transition bias. Transition is a substitution of a purine to 
another purine (C<->T) or pyrimidine to another pyrimidine (A<->G), whereas transversion 
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is a substitution from purine to pyrimidine or vice versa (T«->A, C^G, T«->G, A<-^C). 
For each base there is one possibility to substitute for a transition, but two possibilities for 
transversions, therefore without bias, the expectation is that transversions would be twice 
as common as transitions. However, studies of DNA sequences from both pseudogenes 
and functional genes (Ochman, 2003; Vogel and Kopun, 1977; Vogel and Rohrborn, 
1966) have shown that DNA substitutions are not random and that bias toward transitions 
exists. Based on mutation frequency studies on housekeeping genes sequenced in 
multiple strains of E. coli and S. enterica, it has been estimated that the ratio of 
transitions versus transversions is about 2.5:1 (Ochman, 2003). Therefore, it is possible 
that background generic variance (mutational supply) played a role in the evolutionary 
dynamics in the adapting E. coli population to MCN. It is possible TetX2r280A had a 
greater probability to arise in the starting population, and therefore had an advantage 
from the very beginning over TetX2N37ii or TetX2N.vnT which resulted from transversions. 
The transition bias does not exist in the error-prone PCR generated library, because the 
polymerase and conditions used in this experiment were optimized to remove 
transition/transversions bias. 
The second possibility is that a bottleneck was introduced during the daily transfer 
of a small fraction of a population to fresh media. Based on the mutation rate, size of 
tet(X2) gene (1140 bases), the population size (6.6xl09 cfu/ml) and number of 
generations (-16) in the 50 mL flask, we estimated that 6.7x104 mutations in tet(X2) gene 
were generated in the first 24 hours. Transferring 1/1000th of total population to a new 
flask means that on average sixty seven tet(X2) mutations were transferred, which 
constitutes only 2% of all possible mutations. However, within the next twenty four hours 
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in the 50 ml culture, the sequence space of tet(X2) would be sampled approximately over 
two fold and new variants will be generated. It is important to note, that the mutation 
rates increase in response to stress (e.g. antibiotics) for E. coli (Rosenberg and Hastings, 
2003) and thus this calculation is only a rough estimate since the actual mutation rate is 
unknown. 
We tested the reproducibility of TetX2 mediated adaptation to MCN by repeating 
the serial passage experiment in ten parallel strains under the same conditions as outlined 
previously. If TetX2r280A was the only mutation or was more frequent early on we would 
be able to see this by increasing the sample size through performing the experiment in 
several populations. Deep sequencing of the ten replicate populations was used to 
quantitate the allelic frequency of the adaptive populations. In principle, this method will 
allow us to observe the earlier spectrum of mutations and the whether N371I/T are made 
at comparable frequencies to T280A. 
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Chapter 4: Biophysical characterization of TetX2 and its 
adaptive mutants 
We isolated seven adaptive mutants of TetX2 with single amino acid changes in 
protein sequence that confer equal or higher resistance towards MCN. Resistance was 
measured by growth assays at various antibiotic concentrations and then correlated to the 
catalytic properties of the wild-type and mutant enzymes. 
TetX2 was originally isolated from transposons 7n4351/7>i4400 found in 
Bacteroides fragilis, however its activity against tetracyclines was not realized until it 
was cloned and expressed in E. coli (Speer et al., 1991). Based on amino acid homology 
to NADPH - dependant oxidoreductases, it was suggested that TetX2 required NADPH 
and oxygen for its activity (Speer et al., 1991), which may explain why TetX2 was not 
functional in anaerobic Bacteroides. In vitro activity of TetX2 has been studied before 
using a spectrophotometric assay against a broad range of tetracycline derivatives, 
including the most recently FDA approved tetracycline derivative, Tygacil® (Pfizer) 
(Moore et al., 2005; Wangrong Yang, 2004). These studies showed that TetX2 belongs to 
a family of FAD-dependent monooxygenases and confirmed its requirement for NADPH, 
molecular oxygen and magnesium for catalytic activity. 
Monooxygenases catalyze specific insertion of one oxygen atom into an organic 
substrate (van Berkel et al., 2006). This reaction relies on activation of molecular oxygen, 
which often requires a transition metal bound to a cofactor (e.g. heme in P450 
monooxygenase) or a purely organic cofactor such as flavin (van Berkel et al., 2006). 
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Most flavoprotein monooxygenases contain non-covalently bound FAD as a prosthetic 
group that has to be in a reduced form to react with its substrate (Massey, 1994). 
Reduction most often occurs by reaction with NADPH, enabling the enzyme to react with 
molecular oxygen and leading to formation of reactive C4a-hydroperoxyflavin (Entsch et 
al., 1976). Because TetX2 is NADPH dependant but lacks the common NADPH binding 
fold, it was classified as a class A flavin monooxygenase (Speer et al., 1991). In this class 
of flavoproteins, C4a-hydroperoxyflavin is the oxygenation species that performs an 
electrophilic attack on the aromatic ring of its substrate (van Berkel et al., 2006). The 
most studied class A monooxygenase and thus a model enzyme for this subclass is para­
hydroxybenzoate hydroxylase (PHBH) (Entsch and van Berkel, 1995). Although, TetX2 
shares only 21% sequence identity with PHBH, three dimensional structure comparisons 
of these enzymes (Chapter 5) reveal substantial similarities in their overall folds. This 
structural homology between PHBH and TetX2 suggests some conservation of the kinetic 
mechanism for the two enzymes. 
Previous studies of other FAD-dependent monooxygenases and TetX2 suggest 
that initially flavin is reduced by NADPH so it can react with molecular oxygen to form a 
C4a-flavin hydroperoxide, which regioselectively hydroxylates tetracycline (Wangrong 
Yang, 2004). However, detailed steady state kinetic analyses of the reaction mechanism 
were not performed. 
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4.1. Enzyme kinetics of TetX2 and TetX2T2»oA 
Previously reported kinetic parameters of TetX2 were determined by fitting initial 
velocities into classic Michealis-Menten equation which allowed determination of 
catalytic rates (vj) and Michaelis constant (A"M) for tetracyclines (Wangrong Yang, 2004). 
However, the reaction catalyzed by TetX2 involves two additional substrates: NAPDH 
and molecular oxygen (Figure 5.1). The adaptive mutants could potentially affect 
interactions of any of the substrates with the protein, so we sought to determine the 
Michaelis-Menten constants and steady-state catalytic rates as function of both [MCN] 
and [NADPH]. Ideally, the third substrate, oxygen should also be taken into account but 
varying concentrations of oxygen is very challenging and studies of the catalytic 
mechanism of PHBH have shown that the rate of oxygen binding is very fast and is not 
the rate limiting step (Entsch and van Berkel, 1995). Moreover, the oxygen concentration 
during bacterial growth is held constant for all our fitness experiments. Therefore, we 
focused our efforts on understanding the interactions of the proteins with MCN and 
NADPH and their effects on the rates of catalysis. 
We monitored the progress of TetX2 catalysis against MCN by varying both 
MCN and NADPH concentrations at 37 °C, to closely mimic the conditions under which 
adaptive mutants were selected (see Section 2.6). Because, tetracyclines have two 
absorption maxima at 260 nm and 363 nm and NADPH has an absorption maximum at 
340 nm, the change in absorbance corresponding to MCN hydroxylation alone was 
monitored at 400 nm. 
76 
H3C^ /CH3 
N 
H3C\ /CH3 
N 
H H I Jc\ 
11a j 
A 
10" '11" <^12'/|Xv1''/ 
I II I 6H || 
OH O OH O OH 
NH; 
TetX2, NADPH, 02, MgCI2 
H3C^ /CH3 
N 
H3C^ /CH3 
N 
H H I ^H 
OH O OH O OH 
Figure 4.1. Hydroxylation of minocycline catalyzed by TetX2 in the presence of 
NADPH, 02 and MgCl2. 
The inactivation of minocycline results in the formation of a unstable 11a-
hydroxyminocycline by hydroxylation at position 11a. The product of this reaction is 
further degraded by non-enzymatic reactions to open ring structures that do not inhibit 
bacterial translation reactions (Wangrong Yang, 2004). 
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The initial velocities were measured at various NADPH (12.5, 25, 50, 100, 200 
(iM) and MCN (0, 5, 10, 25, 50, 100, 200 |j.M) concentrations (Figure 4.2.A). As shown 
in Figure 4.2.A, the initial velocities at different MCN concentrations increase with 
increasing NADPH which in turn results in an increase of Vmax(obs)- In addition, the KM(„bS) 
also increases with increasing NAPDH concentrations, which suggests that only binary 
complexes of the enzyme with these substrates can occur and that MCN and NADPH can 
not be bound at the same time in the active site (i.e. no ternary E:MCN:NADPH complex 
forms). The double reciprocal plots (Lineweaver-Burke plots) of initial velocities versus 
MCN concentrations were graphed to confirm the binary mechanism. The expectation 
from this test is that parallel (nonintersecting) lines will be observed if a binary complex 
mechanism is occurring (Lehninger, 2008). In contrast, the kinetic characteristic of 
ternary complex mechanisms, are converging lines in double reciprocal plots, which 
mean that the enzyme forms a complex with both substrates (ternary complex) and the 
Km for the ternary complex has a finite value (Lehninger, 2008). 
In the double reciprocal plots for TetX2, the lines do not intersect and appear to 
have similar slopes (Figure 4.2.B). The slopes are similar because the A^M(obs) for MCN 
shows the same increase with [NADPH] as does the VmaX(obs). which is characteristic for 
binary complex mechanisms, where the two substrates compete for the same site on the 
enzyme. The kinetic parameters; ATM(mcn), ^m(nadph), &cat; reported in Table 4.1 were 
calculated by fitting initial velocities to a simple, rapid equilibrium binary complex 
model for the two substrates MCN and NADPH (Eq. 4.1, Scheme 4.1). 
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ERCD + A ^KA*- ERCDA \ EOX + P 
02 
Scheme 4.1 j<r ^ 
EOX + B E0XB I—ERCD + 0 
. kox[02] 
where k> = 
' ko2 + [0:] 
v = V-("<")[*] where Eq-1-1 
" [A] + KM(obs) 
VmJobs)= Vmax[g] E(JA2 
K . + [ B ]  
and K M ( o b s ) =  
Kb + [B] Eq.4.3 
In the mechanism illustrated in Scheme 4.1, the substrate free enzyme in a 
reduced form (Ered) reacts with the first substrate A (MCN) with an equilibrium 
dissociation constant defined by Ka to form the first binary complex (EredA). This 
complex then reacts rapidly with O2, which is held at a fixed concentration. In our 
simplified analysis, this hydroxylation step is represented by a simple pseudo-first order 
process defined by k\. The net result is formation of the oxidized enzyme and dissociation 
of the hydroxylated and inactivated MCN. This step should, in principle depend on [O2]. 
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The second reaction involves formation of a binary complex between the oxidized 
enzyme (Eox) and the reductant (B=NADPH) to regenerate the enzyme to its active form 
(Ered). The binding of NADPH to Eox is defined by the equilibrium constant Kb- This 
mechanisms shows that both A and B compete for the same active site on the enzyme and 
assumes that the binding of MCN and NADPH is much faster than the hydroxylation and 
electron transfer steps. It is probable that a more complex mechanism applies with respect 
to these assumptions. However, in all cases parallel lines will be observed if only binary 
complexes occur, and the key result for these fitness experiments is how the empirical 
values of KM(MCN), ^M(NADPH) and VMAX are altered by mutagenesis. 
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Figure 4.2. The enzymatic profile of adaptive mutant TetX2r280A isolated by 
experimental evolution implies binary complex formation. 
A) Hydroxylation of MCN by TetX2t280A was monitored at 12.5, 25, 50, 100 and 200 |iM 
of NADPH at 37°C for 5 minutes. The initial velocities were fit to the simple binary 
complex mechanism expression shown in Eq.4.1. B) The double reciprocal plot for the 
initial velocity of MCN hydroxylation at various NADPH concentrations exhibits 
characteristics of binary complex formation with parallel lines indicating identical slopes 
and therefore same dependence of Vmax(obS) and KM(obs> on NADPH. The error bars 
correspond to the standard deviation among three individual measurements. 
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Table 4.1. Steady-state kinetic parameters for wild-type TetX2 and adaptive 
mutants isolated by directed evolution 
^M(MCN) ^M(NADPH) ^cat ^cat^M(MCN) &cat/^M(NADPH) 
(|lM) (HM) (^ max/[Et0tal] (s"') (\iMl s ') (^IM-1 s-1) 
WT 35 ± 1.9 75 ±4.1 0.34 ±0.01 0.010 ±0.0006 0.004 ± 0.0003 
T280A 18 ±0.9 18 ± 1.1 0.43 ±0.01 0.024 ±0.0013 0.024 ±0.0016 
T280S 30 ± 3.4 100 ± 14 0.18 ±0.01 0.006 ± 0.0008 0.002 ± 0.0003 
F235Y 54 ±6.1 99 ± 11 0.32 ± 0.06 0.006 ±0.0013 0.003 ± 0.0007 
N371I 18 ± 1.9 64 ±6.3 0.37 ± 0.02 0.020 ± 0.0024 0.006 ± 0.0006 
N371T 24 ±2.1 130 ± 11 0.40 ± 0.02 0.017 ±0.0017 0.003 ± 0.0003 
S326I 37 ±2.8 73 + 5.5 0.36 ±0.01 0.010 ± 0.0008 0.005 ± 0.0004 
K64R 36 ± 4.6 110 ± 15 0.32 ± 0.03 0.009 ±0.0014 0.003 ± 0.0005 
4.2. Enzyme kinetics of mutants isolated by directed evolution experiment 
All mutant enzymes exhibited similar mechanistic behavior with modest changes 
in their kinetic parameters. The adaptive mutant T280A was the most enzymatically 
active enzyme among all mutants tested with the largest &ca, (0.43 s"1) and smallest KMs 
for both MCN (18 fxM) and NADPH (18 |iM), resulting in 2 to 3-fold increases in 
enzymatic efficiency (kcat/KM(MCN) or kcat/KM(NADPH)) when compared to the wild-type 
TetX2 (A'M(MCN)= 35.4 (J.M, AM(NADPH)= 75 fiM, &cal=0.34 s"1). Both, TetX2N37ii and 
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TetX2n37it have similar lower Km values (18 and 24 p,M, respectively) for MCN when 
compared to TetX2T280A, but the Am(nadph) for TetX2N37n (64 |lM) is similar to that of 
the wild-type enzyme and 3.5-fold higher than that for TetX2x280A- The Km(nadph) for 
TetX2N37iT is 2-fold higher (134 (iM) than the ATM(nadph) of the wild-type enzyme; 
however both the TetX2N37ii and TetX2N37iT mutants show slight increases in /ccat values 
(0.37 and 0.40 s1, respectively) and as a result have similar /cCat/KM(NA»PH) values and 
two-fold higher fcCa/KM(MCN) compared to wild-type TetX2. 
Surprisingly, the kinetic parameters for the bacterial mutants with intermediate 
resistance to MCN, TetX2s326i and TetX2F235Y, are very similar to those for the wild-type 
enzyme, showing no change in the Am (37.4 and 53.9 jiM, respectively) for MCN and kcat 
(0.36 and 0.32 s respectively) and only a slight increase in the A"M(NAdph) (73 and 99 
(j.M, respectively). Finally, TetX2x28os and TetX2k64r show no change in the Am(mcn) (30 
and 36 |iM, respectively) but both have higher /Cm(nadph) values (105 and 112 ^.M, 
respectively) and lower rates of catalysis, particularly for TetX2j28os (0.18 s '). 
The catalytic parameters of TetX2r280A provide a rationale for the selection of 
T280A mutation in the evolution experiment, but don't explain why TetX2N37n and 
TetX2n37it, which have similar enzymatic efficiency, are not observed in the selection 
experiments. However, the in vitro catalytic activity of TetX2s326i and TetX2p235Y alone 
could not be linked to their improved performance in vivo as shown by growth assays. In 
addition to enzymatic activity, adaptive mutations may also affect the physiology of the 
entire organism by altering regulation, expression levels and/or stabilities of proteins in 
vivo (Soskine and Tawfik, 2010). Thus, we investigated protein stability to determine if 
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increases in fitness that are not evident from in vitro activity assays could be due to 
increased resistance of the mutant enzymes to denaturation. 
4.3. Stability of TetX2 and TetX2x280A 
In order to assess the effect of the adaptive mutation T280A on the amount of 
folded protein, the in vitro stabilities of wild-type and TetX2T280A were determined by 
thermal denaturation monitored by circular dichroism (CD). The stability data shows that 
both TetX2 and TetX2j280A have nearly identical unfolding profiles (Figure 4.3.A). 
However, the thermal unfolding midpoint (Tm) could only be approximated as protein 
denaturation was largely irreversible and at least two transitions were observed. The large 
transition occurs at 71.7 ± 0.5°C and 72.6 ± 0.5°C, for wild-type and TetX2T2xoA, 
respectively (Figure 4.3.A). In addition, prior to the sharp transition, a gradual decrease 
in the CD signal of about 5 mdeg is observed between 25-45°C (Figure 4.3.B). 
Chemical unfolding in the presence of guanidinium chloride shows that the change in 
signal for fully unfolded TetX2 is expected to be significantly larger than what is 
observed at lower temperature (Figure 4.3.C). Although, it is unclear what exactly this 
small decrease in CD signal corresponds to, we postulate that it might be due to local 
unfolding, or partial loss of FAD cofactor. Even though, we were not able to assess the 
fraction of folded protein using CD thermal unfolding, we concluded that the T280A 
mutation does not dramatically alter the stability of the enzyme. Since the unfolding of 
TetX2 and TetX2j280A are irreversible and involve at least two transition states, the 
stability of the remainder of the mutants were not analyzed using this approach. 
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We shifted our focus from protein stability to in vivo steady-state protein levels as 
a probable cause of increased fitness despite a lack of increase in catalytic efficiency for 
some of the mutants. 
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Figure 4.3. T280A does not significantly alter the stability of TetX2. 
Thermal stability of TetX2Wjid-type and TetX2T280A was monitored by change in circular 
dichroism as function of temperature. A) Thermal denaturation midpoint (Tm) of 
unfolding is estimated at 71.7°C for TetX2Wjid-type (black solid circles) and at 72.6°C for 
TetX2T280A (red open triangles) for the sharp transition. B) Small change in CD signal 
during thermal unfolding of TetX2 occurs between 30-45°C and precedes sharp transition 
at higher temperature. C) Chemical unfolding in the presence of guanidinium chloride 
(GuHCI) of TetX2 shows a large change in CD between folded (0M GuHCI) and 
unfolded protein (3M GuHCI). 
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4.4. Relative steady-state concentrations of mutant enzymes 
Although direct measurement of steady-state kinetic parameters correlated well with the 
in vivo success or failure for five of the seven adaptive TetX2 variants, TetX2ra5Y, and 
TetX2s326i had kinetic parameters comparable to wild type enzyme (Table 4.1) and yet 
significantly increased growth rates at higher MCN concentrations (Chapter 3, Figure 
3.5). TetX2p235Y» and TetX2s326i also displayed greater than expected growth rates when 
expressed from plasmids (data not shown) and led us to consider whether these two 
variants might be present at higher steady-state concentrations in vivo. Our preliminary 
mathematical model (work by Andres Benitez summarized in Chapter 6) relating 
bacterial growth rates to kinetic parameters of TetX2 had also suggested that in vivo 
steady-state concentrations of TetX2F235Y, and TetX2s326i would likely be higher. To test 
this hypothesis, TetX2 activity was measured from cell extracts of E. coli expressing 
chromosomally integrated TetX2 variants. Based on the specific activities obtained from 
cell lysates (see Section 2.7), the relative enzyme concentrations of each mutant 
compared to the wild-type TetX2 was determined. 
As shown in Figure 4.3, the steady-state protein levels of TetX2p235Y and 
TetX2j28os are ~2-fold higher than the wild-type, also TetX2N37iu TetX2N37iT and 
TetX2S326i appear at -50% higher levels. The differences in the steady-state protein 
levels among the mutants are consistent with the growth rate data, which suggest that 
strains expressing TetX2s326i and TetX2p235Y are better at hydrolyzing MCN than wild-
type TetX2. In addition, higher in vivo levels of TetX2T28os explain wild-type like 
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performance of this mutant in the growth assays, which could not be explained by 
kinetics due to lower catalytic rate. 
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Figure 4.4. Adaptive mutants show differences in their relative steady-state protein 
concentrations. 
A) Specific activities of TetX2 and its potential adaptive mutants were determined 
from cell lysates of chromosomally expressed enzymes in E. coli BW25113. Total 
activity is plotted for strains carrying each mutant allele. B) Relative protein 
concentrations were determined by fitting initial velocities determined in the assay to 
Eq.4.1 and implementing kinetic parameters calculated in the in vitro kinetics assay. All 
data was normalized to the wild-type enzyme. Error bars correspond to standard-
deviation between three independent measurements. Statistically significant differences 
in expression levels were observed for all mutants, when compared to the wild-type (p-
value < 0.05) and were most noticeable for TetX2F235Y and TetX2x280S-
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4.5. Discussion 
The steady-state kinetic parameters determined for the wild-type and mutant 
enzymes provide important insights into the catalytic mechanism of MCN hydrolysis. 
Based on these results and what has been known from studies on the related 
monoxygenase, PHBH, we propose that the mechanism of MCN degradation consists of 
at least two binary complex reactions, one reductive and one oxidative (Entsch and van 
Berkel, 1995). In the reductive step, the enzyme containing oxidized flavin reacts with 
NADPH to form of a binary complex. This mechanism is in contrast to what is observed 
for PHBH, where both NAPDH and p-OHB form a ternary complex (Entsch et al., 1976). 
The parallel lines, shown in the double reciprocal plots for our experiments (Figure 4.2), 
clearly eliminate the possibility of ternary complex formation suggesting that MCN is 
never present in the active site along with NADPH. Thus, after reduction of FAD, 
NADP+ is released from the active site before MCN interacts with the reduced flavin. 
In the second oxidative step, the enzyme with reduced flavin and bound MCN 
rapidly reacts with molecular oxygen to form a C4a-hydroxyperoxide. The position of 
oxygen transfer is conserved among most flavomonooxygenases that react with aromatic 
substrates (Entsch and van Berkel, 1995). The C4a-hydroxyperoxide then reacts rapidly 
with MCN, which leads to formation of a hydroxylated product that is unstable at neutral 
pH. NMR studies with another substrate, oxytetracycline, under acidic conditions showed 
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formation of a monohydration product at CI la of this substrate, which is further broken 
down through a series of non-enzymatic reactions (Wangrong Yang, 2004). 
Overall, TetX2 shares homology with PHBH in terms of function and structure 
(discussed in Chapter 5), however as shown above there are several differences in the 
details in their mechanisms of catalysis. In this study, the mechanism of MCN 
hydroxylation by TetX2 was studied under steady-state conditions, however to truly 
elucidate the fate of FAD, NADPH, oxygen and MCN, a more thorough analysis should 
be performed using rapid reaction techniques such as stop-flow spectroscopy to examine 
the detailed kinetics of the half reactions and the reaction of the EredMCN complex with 
o2. 
The in vitro stability studies have shown that the T280A mutation does not 
significantly change the stability of the enzyme. This may explain why compensatory 
mutations that serve to stabilize proteins would not be necessary for TetX2 and were not 
observed in the adaptation experiment. 
In vivo success of the adaptive mutants was reflected by in vitro catalytic 
performance of the isolated enzymes (except TetX2F23SY and TetX2S326i)- For example, 
when the most enzymatically active mutant, TetX2r280A, was introduced into the 
chromosome of E. coli, we observed a very significant improvement in fitness (240-
575%) at moderate MCN concentrations (10-16 (Xg/ml) compared to a strain carrying 
wild-type enzyme. The same held true for less active enzymes. The in vitro catalytic 
performance of TetX2k64r closely resembled that of the wild-type TetX2, which 
suggested that the growth profiles of these two enzymes should be very similar. As 
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expected, the fitness of TetX2K64R and TetX2 were nearly identical at all MCN 
concentrations tested, showing a tight link between in vitro enzyme kinetics and 
organismal fitness. 
We have asked whether there were any parallels in the way in which these 
mutations influenced the kinetic parameters of TetX2. We observed that cells expressing 
te/(X2)N37u, te/(X2)N37iT and te/(X2)T280A had the fastest growth rates when compared to 
the wild-type stain and that all three mutations caused a 2-fold decrease in A'm(mcn) and 
slight increases in kcat, but had a much smaller effect on the KM for NADPH. The mutant 
TetX2K64R has growth rates comparable to wild-type TetX2 but causes an increase in the 
Km of NADPH while not affecting any other parameters. This result suggests that 
beneficial mutations that alter the efficiency of MCN hydrolysis have larger effects on 
overall fitness and that the bacteria are less sensitive to changes affecting the NADPH 
oxidation reaction, perhaps because the [NADPH] is always above the ATM(NADPH» value in 
rapidly growing cells. 
The molecular mechanisms underlying greater fitness of strains carrying 
TetX2p235Y and TetX2s;?26i could not be directly linked to the in vitro activity of the 
enzymes but rather to the steady-state protein levels in the cell. The effective 
concentrations of proteins in vivo depend on several factors including RNA and protein 
stability, rates of protein folding, as well as changes in protein expression patterns due to 
mutations in regulatory elements (Soskine and Tawfik, 2010; Tokuriki and Tawfik, 
2009b). Therefore, measuring the relative steady-state protein levels from cell lysates 
provide a means to evaluate whether the adaptive mutations affected any of these 
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molecular processes and to relate them to the in vivo performance of the enzymes with 
respect to antibiotic resistance in growth assays. 
We have found that relative to strains carrying wild-type TetX2, bacteria 
chromosomally expressing TetX2p235Y and TetX2x280s showed 2-fold higher steady-state 
protein levels, whereas bacteria carrying TetX2N37n, TetX2N37|T and TetX2S326i had only 
50% higher protein levels. This result shows that single point mutations can cause small 
changes in the effective steady-state protein levels that in turn have large effects on the 
success of particular mutations in the population. 
Overall, the in vitro kinetic studies show that all adaptive mutations exhibit 
surprisingly small changes in kinetic parameters for TetX2 enzymatic reaction in relation 
to the in vivo fitness benefits conferred by bacteria expressing these variant alleles. For 
example, the best mutants TetX2x280A, TetX2N37ii and TetX2N37iT conferred 240% fitness 
benefit over TetX2 at 10 M-g/ml of MCN but showed less than 30% increases in kcat and 
about 2-fold decrease in their respective A"M<MCN) values. In addition, the efficiencies of 
the two catalytic steps, first FAD reduction by NADPH and second hydroxylation of 
MCN, were altered at the most by 5-fold (i.e. kcat/K|vi(MCN), kca/KM(NADPH)) for T280A, 
Table 4.2 ). 
Adaptive mutations with large effects on the kinetics of TetX2 were not isolated 
from the adaption experiment or the error-prone library. Because most proteins are only 
marginally stable, mutations with greatest effects on activity are typically highly 
destabilizing (Romero and Arnold, 2009). Additionally, these destabilizing mutations can 
be costly to an organism because they often lead to loss of function and protein 
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misfolding which is cytotoxic and requires energy for refolding. As a consequence, more 
substitutions with smaller effects on either stability or activity exist (Soskine and Tawfik, 
2010), and those are often selected for because they increase enzymatic efficiency and/or 
total activity, providing a fitness gain and playing an important role in evolutionary 
dynamics. In our experiments, success or failure of a particular mutant at various 
antibiotic concentrations was based on moderate differences in both in vivo steady-state 
protein levels and protein activity. As shown by growth assays, these subtle changes can 
have large consequences on the overall growth fitness of the organisms. Therefore, it is 
likely, that mutations with large compensatory effects on physicochemical properties of 
TetX2 are not observed because they are rare and don't provide net increases in 
enzymatic activity and thus a fitness advantage to the organism. 
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Chapter 5: Structural characterization of TetX2 
The prose, figures and data contained in this chapter regarding TetX2Wjid-type 
structure have been previously presented by Walkiewicz et al. (2011) in the journal of 
Proteins: Structure, Function and Bioinformatics. Quotation marks and references to this 
work have been omitted. 
At the molecular level, it is the interplay between genetic changes and its effect 
on the three dimensional fold and function of a protein that lies at the basis of adaptation 
to a particular stressor. In order to relate mutations identified in the evolution experiment 
to their biophysical origins, we set off to determine high resolution structures of the wild-
type TetX2 and the best adaptive mutant TetX2T280A in complex with minocycline 
(MCN) and tigecycline (TIG). The high resolution structure provides invaluable 
information about the atomic structure of TetX2 and reveals mechanistic details 
regarding mechanisms involved in substrate recognition and inactivation, which can be 
informative for future drug design. It addition, the atomic structure of TetX2 serves as a 
template for mapping the adaptive mutations. 
5.1. Overall structure of TetX2wud-type 
The final TetX2 model consists of 4 molecules (A, B, C, D) with r.m.s.d. = 0.1 A 
between copies, 84 water molecules and R and Rfree of 24.0 and 28.2 % respectively. 
Electron density for residues 11, 248-249 and 6 C-terminal residues was weak and could 
not be modeled. TetX2 shows a very low overall sequence identity with other FAD-
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dependant hydroxylases (21%) (Figure 5.1), but shares several conserved motifs 
associated with formation of an FAD binding pocket and similar overall topology to the 
class A family of oxidoreductases. TetX2 is a monomer comprised of two domains 
binding one FAD molecule (Figure 5.1.A), The larger (N-terminal) domain is mostly 
involved in the interactions with the adenosine ring of FAD, while the smaller (C-
terminal) domain is predicted to play a major role in substrate recognition. 
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Figure 5.1. TetX2 shares common sequence motifs with other FAD-dependant 
monooxygenases. 
Multiple sequence alignment of TetX2 from Bacteroides thetaiotaomicron (TetX2), p-
hydroxybenzoate hydroxylase (PHBH) from Pseudomonas fluorescence, phzS from 
Pseudomonas aeruginosa (PHZS), and salicylate hydroxylase (SAL) from Pseudomonas 
putida shows that TetX2 shares conserved sequence motifs, GXGXXG, DG, modified 
GD, with other FAD-monooxygenases. Sequences were aligned with program 
CLASTALW and represented by BOXSHADE (Thompson et al., 1994). 
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Figure 5.2 Crystal structure of wild-type TetX2 from Bacteroides thetaiotaomicron, a 
FAD-dependent monooxygenase determined at 2.8 A. 
A) Ribbon representation of crystal structure of TetX2 with bound FAD (yellow).B) FAD 
binding is coordinated through a number of hydrogen interactions with residues 
surrounding the FAD-binding pocket. 
97 
P1 a1 yx_P2 ___A p3 ^ a2 
i M N L L S D K N V A I I G G G P V G L T M A K L L Q Q N G I D V S V Y E R D N D R E A R I F G G T L D L H K G S G Q E A  
i ~t r———— 1 1 1 f 1 r » 13 20 30 40 50 CO 70 
a3 
, P4 _A_ p5 a5_A_P6 cx4 ^ 
M K K A G L L Q T Y Y D L A L P M G V N I A D I K G N  I  L S T K N V K P E N R F D N P E I N R N D L R A I L L N S L E N  
'* ?i ' m ' so ' ioo ' no ' 120 ' iio" 
V_P7 P8 p9 A P10 J11 ^ |312 
l1 
D T V I W P R K L V M L E P G K K K W T L T F E N K P S  E T A D L V I L A N G G M S K V R K F V T D T E V E  E T G T F N  
1 m ' 140 ' ISO ' ICO ' 170 ' 180 ' So" 
_
a 6
_ "
7  
-rt_P 1 3  A P 1 4  yv P 1 5  
I Q A D I H Q P E I N C P G F F Q L C N G N R L M A S H Q G N L L F A N P N N N G A L H F G I S F K T P D E W K N Q T Q  
• Jji ' 200 ' 210 ' 220 ' 230 ' 240 ' 2S<T 
a8 ^ a9 p16 P17 
V D F Q N R N S  V V D F  L L K K F S D W D E R Y K E L  I  H T T L S  F V G L A T R  I  F P L E K P V ^ K S K R P L P  I  T M  I  G  
, , _J_ • 575 " 2S0 ' 290 ' 300 ' TUT 
a10 a12 A f\ 
D A A H L M P P F A G Q G V N S G L V D A L I L S D N L A D G K F N S I E E A V K N Y E Q Q M F I Y G K E A Q E E S T Q  
•' 3U ' 320 ' 330 ' 340 ' 3S0 ' 360 ' 37?" 
f\ 
N E I E M F K P D F T F Q Q L L N V  
: 371 ' iso 
Figure 5.3. TetX2 secondary structure. 
TetX2 is composed of 30% helices and 24% (3-sheets. 
5.2. FAD binding in the structure of TetX2wnd-tyPe 
FAD is stabilized in the active site through a network of hydrogen interactions 
with residues from both N - and C - terminal domains (Figure 5.2.B). In TetX2, FAD is 
in an extended ("IN') conformation with adenosine positioned close to the Rossmann fold 
and the isoalloxazine ring extending toward the smaller domain near the putative 
substrate binding site. The flavin binding pocket also contains a highly conserved GD 
motif (residues 310-311) found in most FAD-dependent oxidoreductases (Eggink et al., 
1990). The residues in the GD motif form a specific pocket for the flavin molecule 
through the formation of hydrogen bond interactions between the OS of Asp311 and the 
03' of ribose, and Op2 of the pyrophosphate of the FAD to the backbone amide of 
Asp311. In TetX2, a third DG motif involved in the binding the pyrophosphate moiety of 
FAD (Eppink et al., 1997), that is found in most FAD - hydroxylases, has an Asnl68 in 
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forms highly conserved hydrogen bonds to the ribityl chain of FAD that may orient the 
flavin toward the substrate in the TetX2 active site (Greenhagen et al., 2008). TetX2 
lacks an independent NADPH binding domain which is a characteristic of class A 
monooxygenases (Eppink et al., 1997). 
5.3. Putative active site in the structure of TetX2wnd-type 
The interface between antiparallel (3-sheets (strands P16-20) of the second 
domain and the isoalloxazine ring of FAD comprises the binding site for the substrate. 
We observed additional strong electron density in the (2Fo-Fc) SIGMAA weighted 
composite maps near the isoalloxazine ring of FAD that corresponds to the predicted 
substrate binding site though the identity of the molecule remains unknown (Figure 5.3, 
Figure 5.4). In the TetX2Wiid-typc structure, unknown electron density was found for both 
the P2| and P| (data not shown) crystal forms of TetX2. Although, we were unable to 
determine the identity of the unknown molecule that gives rise to the strong density seen 
in the composite electron density map, we speculate based on its position near the 
isoalloxazine ring of FAD and similar location to the substrate of PHBH that this 
molecule is a natural E. coli metabolite that co-purified with TetX2. The TetX2 structure 
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bound to an unknown substrate is in a 'closed' state and the strong yellow color of the 
crystals suggests that the flavin is oxidized and therefore unable to carry out further 
catalysis. This might also explain the extended conformation of FAD which resembles 
more the FAD conformation of PHBH with substrate bound rather than the FAD in the 
unbound PhzS structure (Greenhagen et al., 2008). 
5.4. Comparison of the active sites between TetX2wjid-tyPe and PHBH. 
Superposition of TetX2 to the well characterized PHBH (Fig. 2C) (PDB ID: lcj3) 
and Pseudomonas aeruginosa PhzS (PDB ID: 3c96) results in an r.m.s.d. of 4.1 A and 
2.9 A, respectively. As shown in Figure 5.4.A, there are substantive differences in the 
structure compared to PHBH in the N-terminal domain consistent with the modest 
sequence identity although the general topology is maintained. The overall comparison of 
the active sites between crystal structures of TetX2 and substrate bound PHBH shows 
that the FAD cofactor is oriented in a similar position in both proteins (Figure 5.4.B) but 
that the specific residues surrounding the predicted substrate binding site of TetX2 
compared to PHBH are poorly conserved, which is not surprising considering that the 
enzymes bind significantly different substrates. TetX2 maintained a highly conserved 
proline (Pro318) that is analogous to Pro293 in PHBH that interacts with the phenolic 
oxygen of the substrate of PHBH. This residue has been suggested to be important for 
maintaining the proper FAD conformation (Palfey et al., 2002). 
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The location of the unknown density in the TetX2 structure closely resembles the 
position of the substrate in PHBH. Arg213 and Met215 in the TetX2 structure are in 
positions to make hydrogen bonds to the unknown substrate in a manner analogous to 
residues Ser212 and Tyr201 in PHBH. In addition, the sidechain of His234 and the 
backbone amide of Gly58 can hydrogen bond with the substrate similarly to Arg214 in 
PHBH. We speculate that Phe224 is similar to Tyr222 in PHBH, which is also important 
for substrate binding. A significant shift of a loop (residues 54-59) between the substrate 
binding site and the isoalloxazine ring of FAD is observed in TetX2 when compared to 
PHBH loop (residues 42-47), which results in an expanded binding pocket that might be 
required to accommodate a large substrate, such as tetracycline. While the natural 
substrate of TetX2 remains unknown, the ability of TetX2 to inactivate tetracyclines in a 
flavin dependent manner together with the structure presented here confirm the role of 
TetX2 as a Class A oxidoreductase. 
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Met215 Arg214 
Phe224, 
Pro318 
Pro293 
Figure 5.4 Structural comparison of TetX2 and PHBH. 
A) Superposition of structures of TetX2 (blue) and PHBH (orange) (4.1 A r.m.s.d.). The 
overall topology of TetX2 is similar to PHBH and other FAD-dependent hydroxylases, 
forming two domains with one FAD molecule and the absence of an independent 
NADHP binding domain. B) Overlay of active sites of TetX2 (blue residues) and PHBH 
(orange residues) with strong unknown density shown in blue and cyan. Residues 
surrounding the active site are not well conserved with the exception of Pro318 (Pro293 
in PHBH). Final (2Fo-Fc) SIGMAA weighted electron density map corresponding to 
FAD and the unknown density was contoured at 1.5a (blue) and 3a (cyan). 
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5.5. Crystal structure of TetX2x280A in complex with minocycline and tigecycline 
In order to better understand the role of TetX2 in tetracycline resistance and the 
potential structural basis for the rise of adaptive mutants isolated from the directed 
evolution experiment, we determined the crystal structures of the TetX2T280A in complex 
with MCN at 2.7 A resolution (Figure 5.5). We compared the crystal structure of 
MCN:TetX2j280A complex to previously solved native unbound (Walkiewicz et al., 2011) 
and substrate bound (7-iodtetracycline,7-ITc and 7- chlortetracycline, 7-ITc) (Volkers et 
al., 2011) TetX2 structures. The overall structure of TetX2T280A is very similar to the 
wild-type TetX2 (r.m.s.d. = 0.34 A; PDB ID: 3P9U) and 7-iodtetracycline - TetX2 
complex structures (r.m.s.d.= 0.24 A; PDB ID: 2Y6Q) (Volkers et al., 2011). As 
observed previously, FAD adopts an elongated "closed" (IN) conformation suggesting 
that it does not undergo conformational change upon substrate binding (Volkers et al., 
2011). In a large cavity at the interface of the two domains of the protein near FAD, we 
identified strong electron density in (2Fo-Fc) SIGMAA weighted composite maps that 
corresponds to the substrate binding pocket, where we fitted MCN (Figure 5.5.A), 
MCN was found in a similar conformation in the active site to previously 
described substrates 7-ITc and 7-ClTc with the hydrophilic portion of substrate oriented 
towards the isoalloxazine ring of FAD (Volkers et al., 2011). Despite large similarities in 
the substrates' orientation, the residues directly involved in MCN recognition were 
altered. In the structure of TetX2r280A, the MCN interactions with the enzyme occur via 
hydrogen bond network formed between 02 and 05 of MCN and side chains of Q192 
and R213. However, the interactions mediated by residues H234 and backbone of G236 
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that were important in the recognition of 7-ITc (PDB ID: 2Y6Q), were not conserved in 
our structure. Based on comparison of TetX2T280A:MCN complex to TetX2wjid-type:MCN 
complex (unpublished data from Prof. Hinrichs laboratory, University of Greifswald, 
Germany) we concluded that these differences are most likely due to the slight changes in 
substrate properties. 
The structure of TIG:TetX2T280A complex was also solved, however at slightly 
lower resolution of 2.9 A. The electron density for TIG was visible in copies A and C and 
was weaker in copies D and B. The electron density for the aliphatic chain of TIG was 
visible only in copy A, although it was weak (Figure 5.5.B). This might be due to lower 
resolution, but also because this portion of TIG molecule is solvent exposed and might be 
more disordered. The orientation of TIG in the active site very closely resembles the 
position of MCN and the other two substrates. Nevertheless, the specific residues 
involved in substrate recognition seem to be slightly altered. Based on our 
TIG:TetX2r280A complex structure, it appears that TIG is stabilized in the binding pocket 
through interactions between D-ring of TIG and backbone carbonyl oxygen of Ala320, as 
well as A-ring amine of TIG and the sidechain of Thr59 (OG). Again, it is difficult to 
conclude whether the differences in substrate recognition are due to specific properties of 
this substrate or because of the resolution limits of this crystal structure. 
The orientation of both MCN and TIG towards the FAD hydroxylation site (C4a) 
appears to be conserved among both of our substrates as well as 7-ClTc and 7-ITc, and is 
achieved by interactions of N5 and 04 of FAD with 07 and 06 of MCN and TIG. In 
addition, binding of the substrates is stabilized by hydrophobic interaction of residues 
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M215, F224, M375, F380 and F382 with the hydrophobic portion on MCN (Figure 5.6). 
These residues form a hydrophobic cavity which was speculated to constitute the putative 
oxygen binding site (Volkers et al., 2011). 
Arg213 
MCN 
Gin 192 
B 
Thr59 Ala320 
Figure 5.5 Active site of TetX2 in complex with MCN and TIG. 
The residues involved in MCN (yellow) and TIG (cyan) recognition are shown in green. 
The final SIGMAA-weighted electron density maps were contoured at la. 
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Met215 
Phe224 Phe380 
Met375 
Asn37 
Figure 5.6. Active site with the hydrophobic residues shown in purple. 
Residues surrounding the substrate binding pocket form a non-polar cavity which forms a 
putative oxygen binding site. 
T280A is positioned on the second (smaller) domain of TetX2 that is mainly 
involved in substrate recognition (Figure 5.8, red sphere). Precisely, A280 is located on a 
loop (residues 280-284) near a-helix 9 (residues 272-279) and is -18 A away from the 
active site of the enzyme. In the wild-type structure, the backbone (N) and side chain 
(OG) of T280 interact with the backbone carbonyl of E276 on the same helix and 
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backbone carbonyl of N201 on the opposite helix (Figure 5.6). In the mutant, although 
the interaction with N201 and side chain (OG) of residue 280 is lost, the backbone amine 
of AT280 hydrogen bonds with carboxyl oxygens of E276 and L277 on the same helix. 
In addition, the side chain (CB) of A280 interacts with the hydrophobic core made of 
residues 1195, F235 and L277. Structural analysis clearly shows that residue at position 
280 is not directly involved in the catalytic mechanism of the enzyme. This strongly 
suggests that T280A, rather than having local effects on enzyme activity, has a more 
global effect. 
Ile205 
Asn20 Th*80 
Cys202 
Leu277 
Glu276 
Figure 5.7 Overlay of crystal structures of TetX2wjid.tyPe and TetX2y280A. 
Crystal structure of TetX2-H80A (red) does not show significant differences in the overall 
structure of the enzyme. In the wild-type structure (cyan), the side chain (OG) of T280 
interacts with backbone carbonyl of N201 and L277. In the mutant, the side chain 
interactions are lost, but the sidechain (CB) of Ala280 interacts with hydrophobic core 
made of residues 1205, F235 and L277. 
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5.6. Library mutants mapped onto the crystal structure of TetX2T280A 
Mapping of the mutations onto the crystal structure of TetX2T280A:MCN complex 
(Figure 5.8), showed that all of the mutated residues, except K64R and S326, are located 
on the second domain of the protein which is implicated largely in substrate recognition. 
Besides the previously described T280A substitution, which was also isolated from the 
directed evolution library, another mutation was identified at position 280, where 
threonine was replaced by serine (Figure 5.8, shown in red). Since serine and threonine 
are similar in size, both have hydroxyl group at the side chains and are located about 18 
A away from the active site, we might expect that this conservative change has a minor 
effect on substrate binding and enzyme kinetics. 
The mutation found at position 235 (Figure 5.8, shown in purple), where Phe 
was substituted to Tyr, is also located on the second domain of TetX2, near the substrate 
binding pocket cavity on (3-sheet 15. While, the side chain of F235 is oriented about 180° 
away from the substrate and it makes van der Waal contacts with hydrophobic residues 
A193, F205, 1237, L277, and F284 in the adaptive mutant F235Y these residues must 
now accommodate a polar hydroxyl group (Figure 5.9.A). As the backbone of Ca of 
F235 is ~5A away from the A-ring of MCN, changes to accommodate the F to Y 
mutation may alter main chain positioning. 
In contrast, the side chain of N371 is oriented directly towards the D-ring of 
MCN (-4.7 A) (Figure 5.8, green sphere, Figure 5.9.B)) at the putative entrance site for 
tetracyclines. Substitution of a non-polar residue (I) or a shorter polar side chain (T) at 
position 371 near the apolar pocket (Figure 5.6.) results in smaller ATM(MCN) and modest 
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increases in kcat. In addition, position 371 is oriented at a hydrophobic cavity which was 
speculated to constitute the putative oxygen binding site for TetX2 and thus changes in 
this area may have effects on the utilization of oxygen for catalysis (Volkers et al., 2011). 
S326I (Figure 5.8, shown in yellow) is located on a-helix 11 parallel to the 
ribose portion of FAD. The non-polar side chain of lie is perhaps well tolerated since it 
can interact with hydrophobic side chains of M316 and A364 on a-helix 12, and thus 
stabilize the structure at this position (Figure 5.9.C). 
Finally, K64R (Figure 5.8, shown in blue, Figure 5.9.D) is located on a loop at 
the surface of the molecule. It is difficult to predict the effect of this very conservative 
mutation on catalytic mechanism of the enzyme; however, one possibility is that the loop 
moves as MCN or NADPH enter the substrate binding cavity. Although there is no data 
revealing the NADPH binding site, a previous study hypothesized based on comparison 
to PHBH that NADPH binding occurs opposite to the MCN end of the active site (near 
R54) (Volkers et al., 2011). 
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7 1 
1 
M 
* 
Figure 5.8. Ribbon representation of TetX2T280A structure with mutation sites shown 
in spheres and FAD shown in yellow. 
The spheres represent the following residues: red 280, green 371, blue 64, yellow 326, 
and purple 235. Two mutations, N371I and F235Y are located directly in the active site 
of TetX2r280A-
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Figure 5.9. Adaptive mutation sites mapped onto the crystal structures of 
TetX2j280A:MCN complex. 
A) F235 is one of the two mutated residues located near the MCN binding site, 
approximately 5A away from its backbone Cot. Mutation at this position to Y is likely to 
result in local changes since F235 interacts with in the hydrophobic core made of A193, 
F205, 1237, L277 and F284. B) The side chain of Asn371 is located approximately 4.7A 
from ring D of MCN, suggesting that shorter residues (T) or non-polar (I) could have a 
direct effect on the interaction with MCN. C) S326 is located away from the active site, 
but on a helix involved in stabilizing the FAD molecule. Substitution to I at position 325 
is most likely well tolerated since this residue would be able to interact with M316 and 
A364. D) K64 is at the surface of the protein located on the loop at the putative MCN 
entry to the active site. 
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5.7. Discussion 
Analysis of the native TetX2 crystal structure shows that TetX2 is a class A 
FAD - dependent monooxygenase, and, like its homologues, contains conserved 
GXGXXG, GD and modified DG motifs that are part of FAD binding pocket (van Berkel 
et al., 2006). FAD is in an extended conformation with adenosine positioned close to the 
Rossmann fold and the isoalloxazine ring extending toward the smaller domain near the 
putative substrate binding site. As previously predicted, TetX2 lacks an independent 
NADPH binding domain which is a characteristic of class A monooxygenases and is 
consistent with the hypothesis that NADPH is immediately released upon FAD reduction 
(Eppink et al., 1997). 
Additional electron density was observed near the isoalloxazine ring of FAD for 
both the P2| and P| (data not shown) crystal forms of TetX2. Interestingly, the additional 
electron density was located in the putative active site of the enzyme and fits with the 
prediction for the substrate binding site based on comparison of active sites for TetX2, 
PHBH, and PhzS. We speculate that TetX2 crystallized in the presence of a substrate 
analogue that might be a natural E. coli metabolite. The TetX2 structure bound to an 
unknown substrate is in a 'closed' state and the strong yellow color of the crystals 
suggests that the flavin is oxidized and therefore unable to carry out further catalysis. 
This might also explain the extended conformation of FAD which resembles more the 
FAD conformation of PHBH with substrate bound rather than the FAD in the unbound 
PhzS structure (Greenhagen et al., 2008). 
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Comparison of the active sites between TetX2 and substrate bound PHBH shows 
little similarity between the residues that might be involved in substrate binding. One 
exception is Pro318 which is highly conserved among most of FAD-dependent 
hydroxylases and plays a role in substrate binding and orienting the flavin in the 
conformation required for catalysis (Palfey et al., 2002). The low conservation of 
residues in the active site is not surprising considering the large diversity of substrates 
that these enzymes act upon, especially TetX2 that modifies tetracyclines which are 
larger in size. 
To gain a better understanding of the mechanisms underlying the increase in 
fitness of the TetX2r280A enzyme, we solved its crystal structure in complex with MCN 
and TIG. Determination of high resolution structures of TetX2j280A was critical for our 
studies because it served as a template for mapping the mutations of the altered proteins 
and it provided insights regarding the mechanistic details of its catalytic mechanism. 
Perhaps, the most surprising finding was that there were no significant differences 
between crystal structures of native TetX2 and substrate bound mutants. T280A is 
positioned on a loop (residues 280-284) connecting a-helix 9 (residues 272-279) and 13-
sheet 20 (residues 285-288) and is -18 A away from the active site of the enzyme. From 
its location on the three dimensional structure it is evident that residue at this position is 
not directly involved in the catalytic mechanism of the enzyme. Although there are many 
cases where the adaptive mutations occur at the active site of the enzymes, it is not 
uncommon to find mutations that alter activity or stability of an enzyme but are distal 
from the active site (Counago et al., 2006). Nevertheless, this finding strongly suggests 
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that T280A, rather than having local effects on enzyme activity, has a more global effect. 
Preliminary molecular dynamics studies on the T280A mutant support a role for the 
mutation in altering protein dynamics (not shown). 
The position of the mutant residues in the three dimensional structure of 
TetX2x280A in relationship to the substrate cavity together with changes in different 
kinetics parameters of the enzymes suggest widely varying mechanisms of adaptation 
through altered enzymatic activity and in vivo stability. The mutations isolated through 
the experimental evolution mapped mostly (except K64R and S326I) to the smaller 
domain of the enzyme that encompasses the active site for the reduction and 
hydroxylation steps in catalysis. However, only residues at position 235 (Figure 5.7, 
violet sphere, TetX2F235Y) and 371 (Figure 5.7, green sphere, TetX2N37ii, and TetX2N.i7iT) 
are within 5A of MCN and likely to be directly involved in substrate binding or catalysis. 
The remainder of the mutants appears to perturb the function of TetX2 via indirect 
mechanisms, perhaps affecting the flexibility of the enzyme. Wang et al. have shown that 
dynamics of the related PHBH protein play a critical role in its catalysis (Wang et al., 
2002). As described previously, while TetX2 does not have a distinct NADPH binding 
domain, it is evident that the active site must undergo significant conformational changes 
to allow the entry and exit of the large NADPH molecule to reduce flavin and allow 
subsequent binding and modification of tetracyclines.This is not the first time that altered 
flexibility and catalysis were directly linked to antibiotic resistance. A recent study of 
metallo-fi-lactamases showed that flexibility is an essential trait that natural selection acts 
upon (Tomatis et al., 2008). 
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Even though TetX2 requires magnesium for its activity, electron density for 
magnesium was not observed in the wild-type TetX2 or the complex structures shown by 
us and others (Volkers et al., 2011). Magnesium has been shown to be essential for 
binding of tetracyclines to the ribosome (Chopra and Roberts, 2001). Crystal structures of 
tetracycline bound to the 30S ribosomal subunit show that the magnesium ion is bound 
by oxygen atoms at carbons 11 and 12 of tetracycline (1 la is the hydroxylation site) and 
oxygen atoms from the backbone of the ribosome (Brodersen et al., 2000; Pioletti et al., 
2001). Why magnesium is required for tetracycline degradation is puzzling and as of 
today its specific role in the catalysis of tetracyclines antibiotics mediated by TetX2 
remains unknown. 
Chapter 6: Summary of Findings and Future Directions 
In the work presented here, experimental evolution and biophysical 
characterization were used to identify and link the physicochemical properties of TetX2 
and the adaptive mutations to increased resistance to MCN. The success of TetX2 
mutants during adaptation to MCN is reflected by moderate alterations in in vitro 
catalytic activity and in vivo steady-state protein levels. Our results clearly indicated that 
genetic changes resulting in very subtle alterations in the molecular properties of 
enzymes (e.g. 2-fold changes in or expression) can have large effects on fitness and 
thereby play an important role in antibiotic resistance. 
Another interesting finding is that adaptation of TetX2r280A broadens specificity 
of the enzyme such that resistance has increased to another newer tetracycline derivative, 
tigecycline, which was not used in the experimental selection. It has been previously 
demonstrated that protein adapting to one substrate can evolve 'promiscuous' function, 
such as binding of new substrates (Aharoni et al., 2005; Tahlan et al., 2007; Tracewell 
and Arnold, 2009). The ability to perform a new function while maintaining activity 
towards the original substrate reflects on evolvability and robustness of the enzyme 
(Romero and Arnold, 2009). In addition, 'promiscuous' function even if several orders of 
magnitude lower provides an opportunity for new adaptations (Arnold, 2009). 
Kinetic studies showed that TetX2x280A was the most enzymatically active mutant 
with the lowest Km for both NADPH and MCN suggesting that this enzyme was most 
efficient at low MCN concentrations and explains its success in the adaptation 
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experiment. Although, more detailed kinetic studies are required to accurately elucidate 
the mechanisms of MCN hydrolysis by TetX2, this is the first study that provides 
evidence for a binary complex mechanism. The kinetic parameters determined from these 
experiments show that TetX2 forms a binary complex with NADPH which dissociates 
from the active site prior to second binary complex formation between reduced enzyme 
and MCN. This finding was supported by crystallographic studies on TetX2wjid„ type and 
the best adaptive mutant, TetX2j280A, in complex with MCN or TIG. Currently, the 
NADPH recognition and binding site with TetX2 have not been elucidated. 
Crystallographic studies of TetX2 in complex with NADPH would provide invaluable 
insight into this reaction, especially that the kinetic mechanism seems to differ from 
PHBH. 
Although, during the course of this study, crystal structures of TetX2 in complex 
with two different substrates were solved (Volkers et al., 2011), the complex structures 
with tigecyciine presented in this thesis represents the first high resolution protein 
structure with this novel antibiotic. TIG remains a very effective tetracycline derivative. 
Due to increased size and decrease in polarity efflux pumps are ineffective in transporting 
tigecyciine out of the cell. Analysis of the TIG binding pocket in TetX2x280A shows that 
the aliphatic portions of TIG, which is the unique modification on this tetracycline 
derivative, is solvent exposed and does not make specific contacts with the protein. In 
fact, most of the interactions of TetX2 with its substrates are mediated through the 
conserved portions of tetracycline antibiotics, it is therefore not surprising that tigecyciine 
and other tetracycline derivative can be accommodated in the TetX2 active site. This 
finding implies that even though TetX2 has not been identified in clinical settings, it still 
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has the potential to provide very broad resistance to a new generation of pathogens. 
Crystal structures presented here can therefore provide guidelines and assist in the design 
of novel tetracycline derivatives that would serve as poor substrates for this novel 
mechanism of resistance. 
The success of TetX2x280A was predicted by experimental evolution; however, the 
in vivo performance in the presence of MCN of two other mutations also predicted their 
success. Whether clonal interference, transition bias or introduction of a bottleneck 
played a role in the outcomes of the natural evolution experiment remains an open 
question. Deep sequencing using DNA barcoding to quantitate the allelic frequency of 
the seven most successful in vitro tet(X2) mutants in replicate populations should address 
this question and assess the role for mutation supply in the evolutionary dynamics of this 
system. We speculate that if TetX2T280A, TetX2N37ii and TetX2N.mT have similar chances 
for success, we expect to observe equal frequencies of each of the mutants within 
populations. Although this experiment will answer the question regarding the allelic 
frequencies in the evolving population, it will not reveal the frequencies of mutations in 
the starting populations. Alternatively, we may find that TetX2T280A is indeed the most 
successful. If so, this would suggest an important role for the Km to NADPH at the low 
concentrations of MCN. 
To assess the background genetic variation, another experiment would have to be 
performed where E. coli population expressing tet(X2) would be grown in a continuous 
culture (e.g. turbidostat) rather than flasks. Performing deep sequencing analysis on 
samples derived from a turbidostat allows propagating a larger population for many 
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generations in a short time with the benefit of decreasing the effects of bottlenecks. Deep 
sequencing of samples derived from these experiments would allow determining the 
allelic frequencies in the starting population. 
The ultimate goal of this project was to test the hypothesis that based on in vitro 
physicochemical properties of potential adaptive mutants; we can build a mathematical 
model that accurately predicts the evolutionary outcomes in populations during 
adaptation to antibiotics. Currently, Andres Benitez (graduate student in Dr. Yousif 
Shamoo's laboratory) is developing a mathematical model to quantitatively describe the 
success and failure of each adaptive TetX2 mutation over a range of MCN 
concentrations. The model incorporates the classic Michaelis-Menten kinetics (£M(MCN), 
KM(NADPH) and kcat). In addition, it uses a hill function determined by the inhibition of 
MCN on growth rates of E. coli BW25113 that is transformed onto the growth rates of the 
TetX2 variants using the steady state equation and fitted using measured kinetic 
parameters as well as three unknown parameters; the diffusion rate of antibiotic, NADPH 
concentration, and the concentration of active protein for each of the individual mutants. 
If a model that accurately predicts the success of TetX2 mutants is developed will it be 
applicable to other systems? This idea could be tested on another bacterial system that 
utilized antibiotics by enzymatic inactivation such as chloramphenicol acetyltransferase 
which is known to confer resistant to choramphenicol. 
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